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PREFACE 
In this monoi:i:raph I have attempted a survey of' the 
literature pertaining to all of' the drugs which have 
been used by the intravenous route, for the production 
of anesthesia. Some of the drugs represent old and out-
moded methods, while others repTesent the newest and the 
most recent discoveries resulting from the endless search 
for a perfect anesthetic agent. However, for the sake of 
completeness, each drug will be discussed as fully as the 
time permits, with as few as possible remarks concerning 
the efficacy or inefficacy of that particular method as 
compared to methods of administration other than intra-
venous administration. 
INTRODUCTION 
The field of intravenous anesthesia has been, from 
the beginning, and still is, one of the most bitterly 
contested points in medical literature. It presents re-
nown scientists championing its cause, and hosts of equal-
ly brilliant men who denounce it with sincerity. It is 
the purpose of this paper to only give the opinlons, both 
pro and con, upon this controversial subject, and not to 
endeavor to decide the issue. The bitter fight between 
those advocating the inhalation route, Bnd those upholding 
the intravenous methods, will be ~iven in a fair and im-
partial attitude by the writer, and if a verdict is to be 
rendered in favor of either, it is left to the reader's 
discretion to do so. 
I am including a brief chapter on the history, describ-
ing the evolution of anesthesia, in general, in order to 
more clearly and logically show the reader the nreliminary 
step by step progress that science has undergone in its 
search for the perfect anesthesia,- the utopia of anesthet-
ists. Intravenous nnesthesia, as other anesthesia, has its 
good and bad points, and a definite place in anesthesia. 
Perhaps it is best to place its choice wj.th the surgeon. 
That evidence which gives the surrr,eon the most peace of 
mind, knowing his patient's condition as he should, will 





"And the Lord God caused a deep sleep to fall upon 
Adam, and he slept; and He took one of his ribs and clos-
ed up the flesh instead thereof". It has been claimed that 
in the "deep sleep" which the Creator "caused to fall upon 
Adsmt1 , is the germ of the idea of anesthesia that has come 
down to us from the dim ages of the past. It is probable 
that primitive man used digital compression of the carotid 
arteries to produce anesthesia, as the inhabitants of some 
countries do today. This method.was practiced by the race 
of Assyrians before performing the operation of circumcis-
ion. Curiously too, the literal translation of the Greek 
and Russian terms for the carotid is "the artery of sleep". 
( 108) 
The ancient Egyptians are believed to have used Indian 
hemp and the juice of the poppy to cause a uatient to be-
come drowsy before a surgical operation. Pliny (108) re-
lates, that they applied to painful wounds a species of 
rock brought from Memphis, which was powdered and moisten-
ed with sour wine. This is the first record of local an-
esthesia with carbonic gas. It is probable that the "wine 
mingled with myrrh", which, according to St. Mark, was 
offered to Christ before he was nailed upon the cross, was 
indeed a narcotic draught, given with the object of lessen-
ing his sensibility to the agony that was forth-coming from 
his persecutors. 
The earliest reference to anesthesia by inhalation 
is contained in the works of Herodatus, who states that 
the Scythians were accustomed to produce intoxication by 
inhaling the vapor of a certain kind of hemp which they 
t.hrew upon the fire. This was probably cannabis indicus, 
or Indian hemp. 
During the fifteenth century, several new drugs had 
been introduced and used as an inhalation, in mixed form. 
The following is the composition of the sleeping sponge, 
and the method used. "Take of onium, of the juice of the 
forest mulberry, of the seeds of lettuce, of the seeds of 
dock, which has large round apples, and of the water-hem-
lock, each an ounce. Mix all these in a vessel, and then 
place it in a new sponge; let the whole boil until the 
sponge consumes it all. Place the sponge in hot water for 
an hour and let it be applied to the nostrils of him who 
is to fall asleep". The sleep produced was so profound 
it often continued for several days. (108) 
Local anesthesia was not unknown during the middle 
ages, snd Cardow recommends the inunction of a mixture 
consisting of opium, celandini, together with oils. Now 
crushed seeds of poppy and henbane were applied as a 
plaster to parts about to be cauterized. Local anesthesia 
was also produced by freezing. During the seventeenth 
and eighteenth centuries the interest in anesthesia began 
to wane and few allusions are made to it until late in the 
eighteenth century. Thus, from the dawn of creation, an 
r-··~····· 
anesthesia for surgical operations had been prActiced to 
some extent, but, owing to the uncertainty of rhe potency 
and action of the powerful narcotics and palliatives ad-
ministered and the dan~er attendinp, their use when exact 
science was unknown, the practice seemed likely to fall 
into oblivion. At last a series of brilliant discoveries 
in chemistry created a new epoch in the history of anesth-
esia. 
The chemical era of anesthesia brought about the dis-
coveries of Priestley about 1767. These led up to the plan 
of Rdmini stering ~ases and vapors of deflni te cor·,o(-,:;::·i t.ton 
through the lungs. In course of time, nitrous ox:i de, ·:hich 
hnd been discovered by Priestley in 1776, was introduced by 
Humphery Davy as an inhalant, and he discovered to his great 
delight that it relieved pain. About this time, Professor 
Thompson of Glasgow was accustomed to amuse his students 
annually by allowing them to inhale ether and nitrous oxide 
until they were intoxicated. It is an extraordinary fact 
that, even in the face of such experiments, no one among 
the investigators who stood at this ttme on the brink of so 
great a discovery ventured over the threshold. The things 
that are the most apparent may be the longest buried, and 
so with the discovery of efficient anesthesia. (109) 
In 1844, however, Dr. Colton, a pupil under Turner of 
London, delivered a lecture at Hartford, Connecticut. Some 
demonstrations for the amusement of the audience were done. 
Dr. Wells who was in the audience induced a Dr. Riggs to be 
4. 
the operator and extract a tooth while under the influence 
of the nitrous oxide. This was done and, as Wells stated, 
without pain. Wells then demonstrated its use several 
succeeding times. He was asked to address a class at the 
Massachusetts General Hosnital, at which time his exper-
iment was not successful, and the whole thing was denounc-
ed as humbug. He became disappointed, his death occuring 
&Je to this, at thirty-two. To Wells, however, belongs the 
credit for having first shown the practicability of produc-
ing insensibility b;r the use of nitrous oxide and estab-
lishing the principle of anesthesia. 
In 1828, Far~day had called attention to the anesth-
etic properties of ether. In 1839, Clarke and Morton be-
gan amusing their friends by the use of ether, just as 
nitrous oxide was first used. Morton began studying the 
more serious side of the unconsciousness brought on by ether, 
and finding his conclusions similar to those of Wells, he 
had the opportunity to use ether on several extractions. 
These proved to be very successful and he obtained permiss-
ionto test his new anesthetic on a surgical patient at the 
Massachusetts General Hospital. The operation was a big 
success and soon after (1846) a meeting was held in Boston 
to decide on a name for the "sleep producing" substance. 
Morton himself chose the name "letheon", but subsequently 
Dr. Oliver Wendell Holmes suggested "anesthesia" for the 
condition, and the word "anesthetic" for the ap:ent. These 
were immediately taken up by the profession and laity. 
5. 
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Chloroform as a substance h&d been known for some time. 
It also passed through a series of more or less amusing ex-
periments, before Waldie and Simpson became aware of its 
practical uses. In 1847, Simpson first used chloroform an-
esthesia with success and reported the same to the Medico-
Chrurgical Society of Edinburgh. The advent of chloroform 
gave an impetus to other investigators, and during the last 
fifty years such aryents as ethyl chloride, ethyl bromide, 
ethylene, amylene, all of the barbiturates, and others have 
been produced, many of which have been abandoned because of 
some defect or the other. 
The induction of general an""sthesia hy the intraven-
ous injection of drugs was first effected in man in 1872 
by Ore; the drug employed was chloral, fifty-three cases 
were reported, in fifty-one of which satisfactory results 
were obtained.(7'7} Further experience however, proved 
that the procedure was not without dang;er and the method 
does not seem to have been further developed until 1909. 
In that year Burkhardt published his application of the 
principle, using solutions of chloroform first, and then 
later, solutions of ether. 
In 1910, Professor Federoff, of St. Petersburg, 
suggested the intravenous adminis+.ration of hedonal. (7'7) 
Then, one by one, ether, hedonal, paraldehyde , and the 
so numerous barbiturates sprung into prominence, each in 
turn occupying the attention of those inflammed with the 
idea of finding a perfect intravenous anesthetic. The 
6. 
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literature concerning the history of this search is far too 
vast to consider at this time, and will be taken up under 
each individual discussion of the separate drugs. 
7. 
INTRAVENOUS ROUTE IN GENERAL 
Five to ten years ago, some men felt that most of the 
old, time honored anesthetic agents were to be discarded, 
and to be replaced bv certain widely proclaimed new anesth-
etics and that the long established inhalation route for 
general anesthesia was to be but little used and that the 
intravenous route would supplant the pulmonary way. A re-
view of the literature on anesthesia, a consideration of 
the reports of anesthetists and their evaluation of the 
experiences with some of the recently introduced anesthet-
ics and methods, compels one to feel that there is no ideal 
anesthetic nor perfect method, that there is no possibility 
at present of discarding either old anesthetics nor old 
methods, and that each anesthetic and method, whether old 
or new, has its definite indications as well as its equally 
definite contra-indications. According to M. Babcock, (81) 
the wrangle over intravenous anesthesia versus inhalation 
anesthesia is a most unnecessary thing, because there is a 
definite time and place for both in +he field of anesthesia. 
Felix Rood, (76) is one of the more pronounced champ-
ions of the intravenous cause, and states that excellent 
though admi .. nistration of anesthetics b•r inhalation are, 
there are certain inherent defects in any method of admin-
istration through the respiratory tract. Although in most 
cases the results obtained by inhala+ion-are good, cases 
very frequently do arise in which the objections to this 
8. 
method F.re of very great importance. An attempt may, per-
ha ~, s, be made here to enumera t.e some of the more commonly 
str-ted difficulties suggested by those opposed to the in-
h;-;lation route. In the first place, one is limited to the 
use of highly volatile substan~es, f'nd it is probable that 
if solubility rather than volatility is the physical factor 
required, the number of nvailable drugs may be ~reatly in-
creased. Rood, (76) contends thRt the respiratory method 
must always in essence, be indirect. The anesthetic is 
absorbed from the vapor introduced into the air passages, 
so th!-1t the dose actually entering the blood is rendered 
vrriable by the variability \t.i th w11ich it enters the chest, 
being subject to all of the accidents of laryna;eal spasm, 
resniratory spasm, and of variations ~n the depth and energy 
of respiration. Another argument common among the support-
ers of the lntr&.venous route is that the exposure of a very 
l: r~e surface of the respiratory tract to an irritRting gas 
must be regarded as a disadvantar:e and dan~er. This seems 
quite logical, because most of us hf:ve at some time inhaled 
a strong breath of ether, and found it quite irritating, 
.snd it seems reasonable that s1Jch a vanor used in a long 
anesthesia mir.:ht at times lef; d to serious comolicr tions. 
In operations upon the mouth, jaws, or pharynx, the difficult-
ies of the SlJrs:>:eon are much increa.sed by his having to share 
the field of operation with the fn~sthetist. It is clear, 
I believe, from t.he various articles, th&t if the direct 
~dministration of the anesthetic by the blood can be safely 
9. 
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effected, it does dispose of all of these difficulties in 
the use of inhalation drugs, and leaves the way very open 
for the intravenous route. 
It is sometimes a little difficult to see the relat-
ive uses and disadvantages of a new medical or surgical 
method in their true perspective; and it seems that one 
of the most important questions connected with the subject 
is a careful consideration of the indications for the em-
ployment of the intravenous method of i.:;nesthesia. Perhaps 
it would be well to enumerate the collective advantages 
promulgated by the advocates of the intravenous route. (1) 
Absences of deleterious after-effects both gastric and 
pulmonory. (2) Introduction of a quantity of saline fluid 
by means of which shock may either be combatted or prevent-
ed. { 3) Absence of pulmonary irritation. ( 4) In certain 
cases the separation of the spheres of activity of the surg-
eon and anesthetist. Points two and four, to me are quite 
plausible arguments, but the others are not as baldly con-
vincing, and need more proof to back them up. 
Infusion anesthesia is by far the more complicated of 
the tv.ro methods, ('7'7) This says Page, accounts for its more 
limited use. 
Bernhard Friedlaender, (67) attacks the problem of the 
deleterious effects of anesthetics from a little different 
an~le. He believes that there are two distinct injuries 
done, namely, injury to the vital functions, and injury to 




more threatening to the life of the org&nism than the latter, 
and therefore, all attention is directed by the physician 
and anesthetist toward the objective injuries of the vital 
functions, and very little thought is given to the matter 
of the psychic element. From the standpoint of vital funct-
ion, Friedlaender, {6?) says that he considers the inhalat-
ion anesthetic "ether" to be the least harmful, and the most 
adantable anesthetic in that respect. But, his contention 
is that any inhalation anesthetic, presents definite possi-
bilities of injurying the psychic element. 
Friedlaender does not stand alone on this point, as 
a review of the literature will show. Many men register 
that definite complaint against inhalation anesthesia with-
out pre-medication or basal anesthesia. The induction of 
an inhalation anesthetic may produce a severe and often 
lasting psychic trauma upon the patient. In turn the psych-
ic trauma will cause shock and will undoubtedly reduce the 
resistance of the organism. (67) From personal experience, 
one knows that the fear instilled in one immediately upon 
placing the anesthetic mask over his face, is often greater 
than the fear of the operation or procedure. 
We speak of intravenous anesthesia as the direct meth-
od of anesthesia because by this method we do not require 
the assistance of an intermediary system, such as the resp-
iratory or the G.I. tract to assist us in our anestheti7.at-
ion. The anesthetizing agent is 9laced directly into the 





the C.N.S. From the point of view of the anesthetic, then, 
the method is direct. Flagg, (79) has summed up the most 
complete, and wholely impartial views on the subject of 
intravenous anesthesia, and lists the advantages and dis-
advantages as follows: 1. The general anesthetic nru.st be 
preceded by an operation under local anesthesia,(meaning the 
lnsertion of the cannula). 2. The preliminaries to the 
administration of the anesthetic involve a loss of nru.ch 
time and, from this point of view, the method is impract-
ical as a routine in the large hospital. 3. The proper 
administration implies familarity with the surp;ical tech-
nique required. 4. The blood presPure is raised, the 
bleeding is increased and the fluid ha_s a tendency to coll-
ect in the abdomen. 5. ·It is an open question as to the 
harm done by the injection of a normal saline solution in 
the bloodstream of a healthy patient. 6. The possibility 
of septic thrombosis must be considered, and the tendency 
to pulmonary edema. The fore-going were all disadvantages 
and the following is a list of the compliation of advantages. 
1. Ideal control of the administ·ration. 2. Not dependent 
upon the rate or the depth of the respiration. 3. The 
minimum amount of the anesthetic is employed. 4. There is 
little or no cumulative action. 5. The technique is suff-
icently complicated to exclude thoughtless expe~imentation. 
The ~~bove a!'e only a few of +he pro and con c11mulati ve 
tho'J,Q;hts concern:i.ng a very argumentative subject, and further 
mol'.'e scrutlnizing consideration will be dealt with in the 





The method of introducing ether intravenously was first 
i.ntroduced by Burkhardt, and his immediate successes encour-
v~ed others to follow. (83) At the Berlin Surgical Congress, 
Kummel was able to report ninety cases. In no case of the 
ninety did post-anesthetic vomiting occur, althou~)l in a 
large number of the cases the operations were done for ab-
dominal diseases of the gravest kind. Burkhardt used an 
ordinary infusing apparatus containing a 5 % solution of 
ether in normal sal:i.ne. He allowed enough of the solution 
to run in to produce anesthesia, then interrupted the stream 
until the patient showed signs of coming round, when the dose 
was repeated. (83) 
It was soon realized that the interruption of the stream 
brought with it a tendency to thrombosis in and about the 
cannula. To counteract this disadvantage two ves~els were 
arr"'nged, either of which could be connected with the cannula 
separately; one contained ether solution and the other held 
normal saline. In this case, the continuity of the stream 
was maintained with the saline in the intervals between r.he 
administration of ether. The great objection to methods of 
administration by periodic doses is that it is necessary to 
produce a greater concentration of the anesthetic in the 
blood after e8ch dose than is essential for adequate anesth-
esia. ( 83) 
This principle was fully emphasized by those to whom is 
13. 
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owed the introduction of the Vernon Harcourt a:ipar2tus. The 
chief modification introduced into this apryaratus by Felix 
Rood, (83) WPS an indicator rendering possible a minute 
graduBtion of the in-flowing s+ream. The BppRratus consists 
of an u-oner reservoir to contain e supply of the solution. 
This reservoir is connected by a rubber tube to n regulating 
chamber. This chamber besides acting as a rer;ulator also 
acts as an indi.cator. And, although the stream of fluid is 
interrupted so that its rate of flow can be seen, the nress-
ure at the same time is not interrupted, but is transmitted 
continuously to the top cushion of air contriined Pbove the fluid 
in the regulating chamber. The fluid then passes from the 
recmlating chamber to the warm" ng chamber and so on to the 
cannula. 
Ether is so~1ble in normal SPline to the extent of 10.8 
ner cent b:r volume. It was found thrt with a. 101 solution of 
ether, a tr>=nsient hemoglobinuria occurred. (83) On account 
of this, Rood used a 5~ solution, Pnd found that no hemo-
globinuria followed. In order to be still more certain that 
thel"e wr s no blood destruction, a number of snecimens of the 
blood were tPken at. intervals throuv.hout several administrat-
ions. These wer'e examtned microscopically, !'nd showed no 
hemolysis. These should be sufficient grounds to s·y that 
the"'e is no blood destruction by this method of nnesthesia. 
The usual preparation of the arm takes place, and a 
little local anes~hetic is injected and the vein exposed and 
the cannula tied in. Strict asepsis must be used. When the 
14. 
cannula is fixed into the vein the solution is at first allow-
ed to flow in rapidly, the regulatin~ tap being turned full on. 
Induction of anesthesia is usually quite smooth and rapid, three 
or four minutes being the average time. (83) According to 
Rood, strugr:ling during induction is rare. The ordinary signs 
of anesthesia, of course occur-- automatic respiration, muscular 
relrxa+ion, and abolition of reflexes. As soon as the smooth 
anesthesia is established, a little experiment will enable one 
to arrive at the minimum amount required, and the apparatus 
can be set to deliver this amount. {71) The noticeable 
features of this anesthesia, according to Felix Rood {83), 
who seems to have been an authority on this type of anesth-
esia, were the regularity and smoothness, and the ease with 
which the anesthetic could be administered, and the great 
rapidity with which the Df:;_tients responded to slight alter-
ations in the dosage. 
The striking advant£Lg~s of the method are seen in those 
cases where the patient is in a condition of extreme inanit-
ion. These patients often leave the table in a much better 
sti;te than they were in before. So that in any case in whid::l 
the pHtient is likely to be benefited by a saline infusion 
either as a means of relieving shock or hemorrhage, or if 
shock is expected, this method has given excellent results. 
The relaxHtion obtained by this method, states Rood (83) 
of the ebdominal wall, is quite equal to that produced by 
any other anesthetic, excepting stovaine, and for any type of 
case in which ether as an anesthetic :is not contraJ.ndicH ted, 
this method has the one great advanta~e of absence of un-
15. 
nleasant aft.er-effects. Some of the records of the German 
sur~ical clinics show that this is a marked feature of in-_.., 
fusion anesthesia. Kummel reported ninety cases, and in no 
case did post-anesthetic vomiting occur. Rood (83) was not 
quite as fortunate in his cases, but out of 136 cases only 
A vomited at all, and of these, three were cases in which 
blood had been swallowed during; the operation. 
Of course, in reading any of the literature on this 
subject, one must remember that when this method was used 
it was far before anyone had even dreamed of the discovery 
of the efficacy of the barbiturates intravenously, and so 
it did seem quite marvelous to them ths.t they he.d found a 
new route and method of administering anesthesia without the 
old bug-bear of post-anesthetic nausea and vomiting •. 
As a general criticism of the method, it was sug~ested 
by many that it was too complicated a procedure. Rood (83) 
admits this, but st.ates that any great simplification of the 
technique or apparatus might lead to tlie adoption of an im-
promptu method with possible disasterous results. It must 
indeed, have been a huge and clumsy piece of apparatus, but 
from the records it must have also been a fairly efficent 
mode of administration. 
Schlesinger, ('71) in his discussion of this mode of 
ad.mini st.ration, stated that intra venou. s methods of giving 
ether hF.d a very definite but limited application. At this 
time the battle w&s waging over the superiority of ether 
over hedonal when given b;r infusion, and he claims that the 
advantaqes of ether over hedonal were that the patient came 
16. 
round more rapidly; that ether was excreted by the lungs Hnd 
caused much less bleeding, and that no vomiting occurred with 
this method. He also stated that thrombosis, if it occurred, 
was due to faulty technique. 
One of the questions that immediately comes to the reader's 
mind, is how much was the total amount of ether introduced by 
this method in attain:i.ng anesthesia? Schlesinger ( '71} makes 
the following statement concerning this point. "The ether 
solution is allowed to flow rapidly until the patient is anes-
thetized, which requires about 10 m-tnutes of time, and 8 
ounces of the solution. After anesthesia is established the 
rEte of administration is much slower, about 16 ounces of the 
solution per hour being ordinarily sufficent." Felix Rood, 
('76) reports one case of 3~ hours adm:tnistration, in which. 
4~ ounces of ether and 4~ pints of saline solution were used, 
and several cases of over two hours duration. Flagg, ('79}, 
states that the amount of the solution adm"nistered depends 
upon the duration of the anesthesia, and that this amount 
varies from 500.-3500. c.c., with 1000. c.c. per hour being 
the averaP-;e. 
H. Kuttner, (74) one of the first to use the method 
in suri;;ery, cautioned ap.;ainst the dan2'.er of air embolus End 
thrombosis, but these dano:ers were greatly diminished by the 
con+inuou.s flow system. Goyane' s advocacy, (74} of the plan 
of introducing the ether and saline i.nto an artery was not 
well responded to; indeed, the advant&~es celaimed for the 
method hardly counter-balanced its obvious dangers. Th:is 
1'7. 
much had been demonstrated in the very e1;.rly days of ether 
anesthesia, "b7 Flourens and Claude Bernard. Professor 
August Bier, Dr. J.L. Ransohoff, and others sought to avoid 
these perils by localized intravascular injections of various 
drugs cut off from the general circulation bY ti!thtly fitting 
bands, but this procedure was of limited application. (74) 
At this time, intraveno·,1s infusion was confined to the use 
of ether, hedonal, and less frequently wlth that of parald-
ehyde. (72) At this time also, Chloroform was employed in 
this way, but it was found to be so highly dangerous, that 
it was soon cast aside b~~ those in search of new intravenous 
Fnesthetics. The infusion anparatus used for all of these 
drugs was the same, and the apparatus was such a unique and 
complicated mechanism, that I think that it would be of 
interest to take it up here, in a more detniled manner. 
As stated before, F.S. Rood (76) elaborated the apparatus. 
It consisted of a glass reservoir capable of holding about 3 
pints of saline containing ether, this reservoir was controll-
ed bY a stopcock and connected by a rubber tube with a reg-
ulRting chamber. This chamber had three openings, one 
uniting it with the reservoir, one connecting it by a rubber 
tube with the warming chamber controlled by the stopcock, 
and one that e>.dmi tted. Hir, and yet was capable of air tiJ?,ht 
occlusion by means of a rubber stopper. When the reservoir 
tap was opened ~nd the regulatin~ chamber tap was closed, the 
saline ether solution entered the regulating chamber and as 
18. 
soon as this was half full, the air inlet was closed by insert-
ing the stopper. As a result the air in the chamber became 
compressed by the fluid in the chamber, so th 0 t the fluid, as 
it escaped from the regulating chamber into the warmtng 
chamber was under pressure, and so passed in a continuous flow 
into the tube connected with the cannula. The warming chamber 
was immersed in warm water, the ob,iect being to warm the sal-
ine to a temperature below that. at whlch ether escapes in 
bubbles. This chamber had its egress tube nearly half-way 
below its summtt so that any air or volatilized ether would 
rise to the top of the chamber while only fluid went through 
the egress tube. 
In administering ether thusly, full flow was permitted 
at first and in a mtnute or so the patient's breath would 
smell of ether, and anesthesia would rapidly follow. The 
ether supply was then lessened, but cessation of flow was not 
allowed because of dan~er of clotting in the cannula and sub-
sequent danger of emboltsm. It need hardly be pointed out 
that the utmost vigilance was necessary in watching the signs 
of anesthesia, lest the flow be too great and ultimate death 
occur. Koenig, (74) and others asserted that fat~l accidents 
often resulted from excessive quantities of saline-ether 
entering the cir011lation by over-sight. It has been shown 
that saline solution rapidly leaves the blood vessels, and 
Professor Bayliss, (74) proved that the addition of gum 
P-cacia p,..evented this, so bringing un the change by many, 
and substitution of the Bayliss gum saline as the vehicle 
19. 
for ether. 
This method while now frowned on, and laughed at, at one 
time was thought to have the ultimate of desirable qualities 
and may have had as enthusiastic following as some of our 
present day drugs have. Many thought that the possibilities 
of this new anesthesia would be unlimited. By this method 
anesthesia was induced without struggling or discomfort, it 
wns light in character, and the patient resumed consciousness 
within a few moments after cuttin~ off the ether solution, 
i:ind so little wonder that it was thought to be a new hnd 
wonderful discovery and a boon to future anesthesia. 
Buxton, in his book "Anesthetics 11 , ('74) states, "the 
type of patient that suggests saline infusion to stave off 
shock is peculiarly appropriate for intravenous etherization. 
Abdominal sections, especially in acute cases, are quite 
suitable. The young and the a~ed lend themselves equally to 
it if due care is tHken to limit the amount infused to the 
capacity of the patient". He evidently was a firm believer 
in the efficacy of intravenous ether, but to me, the joker in 
the above quotation lies in the last 16 words, for that is 
exactly where intravenous ether fell down, and most of the 
products that supplanted or succeeded it, as someone's idea 
of the ultimate of desirable qualities in producing anesth-
esia, also lost face and failed in that respect of dosa~e and 
its determination in individual cases. There are many men who 
even staunchly hold to the principle that one of the basic 
requirements of an anesthetic is that it does not conform to 
----
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the title, "a fixed dose drug", and c-i.s will be shown later, 
their reasons for F· dherence to this principle are quite 
sound. 
Flagg, (79) sums up the question of intravenous ether-
ization with the following points in reference to the 
relative advantages and disadvantages of its use. The 
advantages are as f'ollows: 1. Ideal control of the ad-
ministration; 2. It is not dependent upon the rate or 
the denth of the respiration; 3. The minimum amount of 
the anesthetic is employed; 4. There is little or no 
cumulRtive action; 5. The technique is sufficently com-
plicbted to exclude thoughtless experimentation. The 
disadvantages of the method are: 1. The general anesth-
etic must be preceded by an operation under local anesth-
esia; 2. The preliminaries to the administration of the 
anesthetic involve a loss of much time and, from this 
point of view, the method is impractical as a ront1ne in 
the large hospital; 3. The proper administration implies 
familarity with the surgical technique required; 4. The 
blood pressure is raised, the bleeding is incre~sed and 
the fluid has a tendency to collect in the abdomen; 5. 
It is an open question as to the harm done b'r the injection 
of a normal saline solution in the bloodstream of a normal 
. healthy patient; 6. The possibility of sentic thrombosis 
must be considered; 7. This author believes thet there is 
a tendency towards pulmonary edema. 
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HEDON AL 
In the extensive search for new derivatives of the 
known dru~s, the discovery of Hedonal was made. Hedonal 
was made from the secondary methyl-propyl-carbinol bv 
he.sting it with urea nitrate under pressure. Thus, it 
was a derivative of urethane, and possessed the chemical 
formula C6Hl302N. It was used quite extensively for the 
production of anesthesia by intravenous infusion, but 
unlike its cousin, urethane, it was soon discarded, nnd 
fell into disfavor a few years after its discovery. (70) 
Hedonal is a white crystr.lline solid, stable at the 
ordinary temneratures. Its solubility in water at 100. 
degrees F. is 1 in 100., and it readily crystallizes out 
of a saturate& solution in long, fine needles. This 
solution ce.n be boiled without the prope·,,.ties of the drug 
being affected. However, prolon·!ed heating diminishes 
the concentration owing to the volatilization of a certain 
amount of the compound. 
In 1910, Professor Federoff, of St. Petersburg, suggest-
ed the intravenous administration of hedonal. (77) However, 
since 1900 this drug had had some voo;ue as a hypnotic; it 
had also been given by mouth (in several Russian clinics) 
as a precursor of chloroform and ether with sattsfactory 
results. Reports of its use as a general anesthetic first 
appeared in Russian journals, a preliminB.ry note was nub-
lished in German in 1910, and in the following year the 
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technique employed, was described by Jeremitsch, with the 
details of sixty-five cases. (77) Later, at the Congress 
of the German Surgical Association, Federoff contributed 
a brief account of 530 cases collected from three Russian 
clinics. The high-light of the report WES th.B t there was 
no death directly attributable to the anes~hetic in the 
series. 
Experiments on animals by Dreser ('77), showed that 
hedonR-1 had 10 tlmes the hypnotic effect of urethane and 
twice that of chloral; he found that the respiration was 
no materially affected in conditions of deep narcosis, 
although it did cause a sliltilt fall in the blood pressu~e. 
Dreser noted that the drug had a diuretic act5on, wh1ch 
was attributed to the theory thht in the body the substance 
was broken down into urea, carbon dioxide, and water. 
Lamusakow ('77) carried ont further experiments, and found 
that in do~s and rabbits, a dose of 0.4 to 0.5 grams to 
the kilo of body weight produced ~eneral anesthesia, and 
that the respiratory and cardiac rhythm remained regular 
under this dose. When he gave toxic doses, the heart 
continued beating, r.fter paralysis of the vasomotor center. 
He considered that the presence of the ami.no radical antag-
onized the paralytic action of the drug. 
Federoff and Jeremitsch, after havtng satified them-
selves by experiment on anim1:,1s, adopted the use of hedon-
al as an anesthetic for man. They employed an interrupted 
infusion method, a 0.'75~ solution in normal saline was 
injected under air pressure. The needle was inserted into 
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a superficial vein, and sufficent of the hedonal solution 
wt:s injected to produce anesthesia; the needle was then 
withdrawn and reinserted if a prolonged anesthesia was 
necesRary. The results obtained were, on the whole, 
satisfactory, but less so when leg veins were injected. 
C.M. Pa~e, (77) whose apparatus for intravenous infusion 
was later modified by z. Mennell, used this means of ob-
taining anesthesia in a number of cases, and regsrded it 
as a valuable method. However, he did caution against its 
employment in what he chooses to call "unsuitable cases". 
Page found that the average amount of hedonal solution 
required to produce anesthesia was 500. c.c., and that the 
induction period ranged from 2. to 13. minutes. He found 
that the narcotic effect of the hedonal nersisted for a 
lon~ time after the infusion had ceased, and remarked that 
this was a Ve!"J undesirable feature of the method. Another 
undesirable feature was the fall in blood pressure and +he 
appearance in a great many cases of cyanosis 1 Pa~e noints 
out as a possible dan~er the onset of cyanosis, and Federoff 
recorded some instances of temporary cessation of respir-
ation. {77) 
Hedonal, as supplied by Bayer, is dissolved in normal 
saline at a temperature of ryo. degrees F., to make a 0.75~ 
solution; the resultant fluid is filtered once, boiled for 
five minutes, and stored in sterile flasks. The contents 
of the flask are warmed up to about 140. degrees F., and 
poured in a tank, which is furnished wtth a thermometer 
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gauge and tapped exit tube. From the latter runs a yard 
of pressure tubing; in the course of this a dropper is 
inserted; it terminates in an ordinary fine infusion 
cannula. Before infusing, the temperature of the fluid 
in the tank is reduced to about 115. degrees F. The 
usual exposure of vein is done, and the cannula tied in. 
The fluid is run in at a rate of 50. to 150. c.c. per 
minute. The rapidity of flow can be accurately controll-
ed by regulating the tap of the tank and watching the 
flow throu~h the dropper. 
Within a minute or so of the commencement of the 
infusion, the natient becomes drowsy, and often ya¥ms; he 
hfls a subjective feeling of WHrmth and well-being, the face 
flushes, and if the infusion is too rapid a certain degree 
of cyanosis arises. (77) Then follows a period in which 
the patient appears to be in a state of deep natural sleep, 
and this state quickly merges into one of deep anesthesia. 
The amount of fluid necessary to induce anesthesia 
varied considerably-- e.g., 40. c.c. sufficed in a child 
aged 10 months; 1,000. c.c. were necessary in a heavily 
built man, aged 25; the average dose necessary in an 
adult was found to be 500.· c.c. As stated before, the 
period of induction varied from 2. to 13. minutes. 
The rr:te of return of complete consciousness is slow 
&nd varinble, and to most of the experimenters this was 
recognized as a serious draw-back to the use of the drug. 
Usually the patient slept for six to twelve hours after the 
25. 
cessation of the anesthetic and then awakens. Drowsiness 
often persisted for twenty-four hour~. In some art~cles, 
I notj_ced cases where numerous ~imes emotional disturb-
Fnces occurrf:d, E..:ncl ;;, 1Jeriod of excitement came on an hour 
or so after the operation. This too, is certainly a auite 
undesirable feature. On further reading, I found numerous 
cases where vomiting and headache·were common occurences. 
Some of the dangers of hedonal anesthesia are cyanosis, 
postoperc..tive excitement, and resnira+-ory failnre from over-
dosage. Federoff, (77) reported that temporary stopnage 
of respiration occurred in eight of 530. cases, but that 
after the use of artificial respiration, normal b~eathing 
started again. Some of the other undesirable features 
noticed were the prolongation of narcosis after the operat-
ion, esnecially with reference to the possibilities of 
inhala~ion of vomitus. 
The sponsors and champions of hedonal administration 
claim the following advantages in it,s use. The technique 
is simple, the solution is re<o.dily handled and steriliz-
ed, and the active part is not volatile. Here arises the 
question as to the relative advantage or disadvanta~e the 
volatility of the drug offers. To me it seems as though 
volatile drugs should be safer, because of t.he mor>e. prompt 
and effieent elimination attained by way of the lungs. As 
one can see by looking over the advantages listed above, 
e.ny and all of them, are certainly open for argument, and 
far from convincing. The rest of t.he advantages given by 
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those championin~ t.his drug, I will merely state, without 
comment, and the reader can take them for what they are 
worth in his consideration. Page, ('7'7) concludes with the 
stBtement that, "the anesthesia attained is of [-; stead;r and 
complete type, the relaxation of the muscles is remarkable 
being often as good as that p;iven by sninal [,nesthesia. 
The respiratory movements are steady rnd quiet. The re-
moval of the ~nesthetist from the scene of the operation 
in herd and neck cases is a distinct advanta~e. The quiet 
sleep, insensitiveness to pain, and nbsence of straining 
1-1re other <dv;ntages." There are other statements, too 
numerous to list, but one of them that I found listed as 
an edvantage, seems to back-fire and act as conclusive 
evldence as to the drug's undesirability. The statement 
is BS follows, "owinp: to the comnaratively slow rrte at 
which the drug is excreted, ve -,y small quantities of the 
solution suffice to maintain anesthesia when once it is 
completely established." ('7'7) The fact that it :i.s slow-
ly excreted seems to me a distinct disadvantage, because 
I believe, at the present +ime, the general consensus of 
opinion is that the faster the rate of elimination, the less 
toxic the drug becomes, and the. more desirable it is as 
an enesthetic. 
It was found that hedonal infusion was unsuitable 
for cases in which nulmonary engorgement or a gross 
cardiac lesion existed, for operations unon the air-
nassap;es, fand for patients with high blood pressure. 
The experiences of the ~re&ter share of those working 
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with this type of anesthesia, confirmed Burkhardt's views 
of the danger of :tntravenous hedonal. ('75) Not only have 
~reat complications arisen from its administration, but 
deaths have resulted from its use. ('74) A discussion on 
the use of hedonal, held before the Medical Society of 
London, provoked somewhat diverse views, but the consensus 
of opinion was ar,ainst the use of intravenous hedonal. ('78) 
28. 
SOMNIFAINE 
The men who have done considerabl·e work in the field 
of anesthesia with this drug, and those who have been its 
chi.ef advocates, are, in the vast majority, workers on the 
European continent. Comparatively little literature on 
this subject has been written by clinicians of England 
or the United States, and the tise of this drug has never 
been accepted, in these countries, with much enthusiasm. 
This drug is really a combination of two hypnotics which 
are derivatives of the malonyl-urea group. The two sub-
stances are diethyl-barbituric acid and allyl-isopropyl-
b&rbituric acid. This combination received considerable 
attention in Europe since 1921, but seems not to have 
interested the profession in this country to any great 
extent. 
Its origin, in 1920, is cre~ited to Redonnet, and 
Cerne was the first to use it in relieving the pains of 
labor. (19} During 1921-1923, Bardet and v. Cleisz 
developed its clinical use in obstetrics, and Fredet 
and Perlis used it in minor surgery, later extending its 
use to major surgery. Since then, there have been in the 
foreign literature quite a number of articles by v~rious 
authors. The results reported have been variable. In 
1925, H.M.F. Behneman after seeing an article on its use 
interested O.H. Schwarz of Washington University in the 
drug. Before trying it clinically however, Schwarz 
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wanted to have some experimental data available, and 
Behneman and Woodmansee undertook an investigation of 
the substance at 1Nashington University, St. Louis, 
under the direction of the Denartment of Pharmacology. 
Their results were not nublished and clinical use of 
the drug was not attempted. However, I. Macdonald, (60) 
states that in 1926, in France, the experimental and 
clinical researches of Fredet and his associates on the 
use of somnifaine, or somnifene, as the drug was known 
in France, seemed to show tha-e in intravenous in.i ection 
for surgical anesthesia, the general anesthesia was 
reduced to an extreme minimum, a.nd in some cases it was 
eliminated entirely. Hewer, (58) in his general discuss-
ion of anesthetics, states that since the Great War, the 
i.ntravenous injection of somnifaine has been practiced 
in France, to a certain extent, but the excitement seen 
was regarded as too detrimental for its common use. 
The drug, as said above, :ls a combj.nation of diethyl-
barbiturate and allyl-isopropyl-barbiturate, in 2. c.c. 
Ampoules, containing 0.10 gram of each drug in the form 
of a diethylamine salt. The solution is rendered stable 
by the addition of small amounts of alcohol and glycerine. 
Recently, a new form has come into use in ampoule form, 
in which the allyl-isopropyl-barbiturate is the only 
constituent. This form was advocated bv Fredet, (19) 
and I. Macdonald. (60) According to the foremost worker 





the reason for the preference of this new drug, over . 
the use of the old combination, is that the diethyl-
barbi turate in the old drug, was eliminated rather slow-
ly, and had, therefore, a delayed end prolonged effect 
which, in the opinion of most, was undesirable. 
Allyl-isopropyl-barbiturate has the highest lipoid 
solubility of all the barbiturates so far kno\im, a feat-
ure which according to the most up to date conceptions, 
( 19) is of prime importance as regards the hypnotic acti.on. 
Due to this high degree of lipoid solubility, it acts 
very quickly, so that sleep arises within a few minutes. 
According to the literature, allyl-isopropyl-barbiturate, 
is about five times as hypnotic as, for instance, diet-hyl-
barbiturate, while its toxicity is not increased in the 
same ratio as its hypnot-ic influence. According to J .H. 
Fjelde, (19) on the other hand, this hypnotic influence 
does not last longer than desirable in the ordinary cases, 
because the elimination of the drug, from the system pro-
ceeds rapidly. This drug should, therefore, leave the 
patient free from prolonged after-effects, a feature 
which is of great importance in general medicine, and also, 
owing to the rapid elimination even of large doses, the 
chances of cumulative effects should be likewise p;reatly 
reduced, when the drug is used over long periods of time. 
Later on, 1_n th~ clinical consideration of the drug, we 
will see if this holds true for this drng. 
Macdonald, (60) states that the interesting research 
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done by Fredet, demons~rates that the seat of action of 
Somnifaine is chiefly in the nerve centers, while J.H. 
Pjelde, (19) is even more specific, and claims that the 
action seems to be exerted directly on the sleep center. 
The drug is car.,-·ied by the red cells, for which it shows 
a special affinity. It is fixed with predominence in 
the nerve centers, but is retained to only a very slig,ht 
degree by the liver, kidney, and other tissues. When 
introduced into the blood, it is eliminated unchanged by 
the kidneys, Hnd elimination commences very soon after 
injection. (19} 
Somnifaine, in non-toxic doses, but of sufficient 
strength to produce anesthesia, exert only a slight effect 
on the respiratory and cardiac centers, and the blood 
pressure also shows very little alteration. F.ielde 
says that there is a slight lowering of the pressure 
after injection, but that this quickly recovers. The 
liver function likewise is not altered. That the glyco-
regulatory mechanism is not affected, w&s demonstrated 
by spontaneous p:lycosuria after injedtion of sugar. 
Fjelde's interest in the intravenous form of obstet-
rical an?sthesia led him to obtain the drug, and in 
October, 1926, with Kent E. Darrow, he started to use it 
in various surgical conditions. He also used it in about 
100. obstetrical cases, and states that the results were 
r:enerally good. In surgery, he usually combined it with 
local or caudal anesthesia, or ethylene, the latter 
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combination was the most frequently used. 
In using somnifaine in surgery, there are two dist:i.nct-
ly different pha.ses of its use: first, the preoperative 
preparation for ethylene anesthesia; and, secondly, actual 
anesthesia for abdominal operations, or in combination 
with a local anesthetic. To Fjelde, (19) the first one 
is the more important method, because by its use, he has 
practically eliminated the use of ether, and does every 
type of ~bdominal operation with ethylene alone. He 
claims this to be a distinct advanta~e because of the 
occasional difficulty in obtaining good relaxation with 
ethylene alone. He states also, that the use of this 
combination of somnifaine and ethylene cuts down the 
ethylene necessary to one to two gallon~ per minute, instead 
of the usual two to three, and the nercentage flow is cut 
to one half the maximum, supposedly, when fifteen to 
ei~hteen per cent oxygen is used. 
The technique of Fredet 1 s method, as stated by I. 
Macdonald, (60) is as follows: 1. A hypodermic injection 
of morphine is given, verying from a minimum of 1. cg. up 
to 2. cg. as a maximum. It is advanta~eous to associate 
scopalamine with the morphine in doses varying from two-
thirds mg. up ·to three-quarters of a mg., according to the 
weight of the patient, and whether his general st&te is 
cachectic or satisfactory. 2. From 20 minutes to 40 
minutes later, after the morphine-scapolamine injection, 
the intravenous injection of allyl-isopropyl-malonyl urea 
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is made very slowly; 3 mjnutes, at le&st, should be 
snent in the injection. The dose is calculated Hccord-
ing to weight, age, and the general state of the patient. 
Generally, in fairly robust adults, 1. cg. per kilogram 
of body weight is used, never passing 0.07 gram; In the 
aged or cachetic patients, 0.04 or 0.03 gram should be 
enough. Ampoules of the drug were obtainable containing 
0.01 gm. in each cubic centimeter of water. 3. Five 
minutes after the in+-r&venous injection a small amount 
of chloroform or ether was given to pe~m1t the incision 
being made about 10 minutes after the intravenous inject-
ion. During the operation the !'.!eneral anesthetic could 
often be dispensed with, to be resumed should the patient 
move and at the end, to facilitate the suturing of the 
wound. 
According to Macdonald, (60) postoperative vomiting 
was very rare, and the patient awoke four to five hours 
after operation to fall asleep quietly a~ain. He does 
admit that excitement was frequently observed, and this 
seems to be also the point that most clinicians found to 
be unfavorable to its use. Macdonald used this anesthesia 
in 33 cases during a period of 2 years, and, although it 
did not replace routine methods, it was his choice in 2 
types of cases,--when the patient was a bad risk from 
pulmonary complic:tions or from probable hepatic and 
renal insufficency, and again when he was certain that 
the operation must be prolonged. 
In the Cardiff City Mental Hosnital about 50 cases 
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were treated with Somnifaine during a two year interval. 
The results, according to Quastel, (103) were definiteiy 
encoura~ing except in so far as toxic symptoms, including 
the production of ketosis, were demonstrated in a large 
percentage of the cases. The toxic by-effects were often 
so slarming thrt it became neces~ary to discontinue the 
treatment. It was felt, however, that the success obtain-
ed in the prolonged narcosis treatment of many cases of 
mental disorder warranted a search either for new drugs, 
which would produce sufficently deep narcosis without the 
demonstration of toxic by-effects or for a modification 
of the then present methods of obtaining narcosis, which 
would diminish or eliminate the toxic action. 
The toxic effects of narcotic treatment with the use 
of somnifaine, have been described bY A.M. Meerloo, and 
M. Muller (103). These include bulbar symptoms, such as 
deran~ements of swallowing mechanism, indistinct speech, 
ataxia, tremor of the lips, and vasomotor paralysis. A 
frequent accompaniment of prolonged narcosis is the de-
velopment of ketonuria, which becomes more marked as the 
narcosis proceeds. Doubtless, the effect has much to do 
with the actual dosa.r;e of the nHrcotic, certain patients 
responding more vi~orously than others. In the past, it 
has always been considered advisable, according to 
Quastel, (103) to cut short treatment with somnifaine as 
soon as a definite ketosis has been produced, and con-
sidering the drug as a whole, he sta+es that he believes 
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it is very rdvisable to entirely dismiss it from clinic-
al use, until some change has been made whereby the 
present dangerous ·toxicity has been decreased to a very 




From the formation of the word, we would expect to 
find that aldehyde had been ns.med bv the Arabian alchem-
ists. On the contrary, the dru~ is of comparatively new 
discovery and was named by Liebig, (110) who contracted 
the name alcohol-de-hydroi:r,enatum, to aldehvde. Aldehyde 
is prepared from alcohol by the action of manganese di-
oxide 'nd sulphuric acid gently heated toaether. Paral-
dehyde is formed by polymerization or linking together of 
three moiecules of aldehyde and is rrepared by adding a 
small proportion of pure sulphuric acid to acetaldehyde. 
Paraldehyde is a clear, volatile, inflammable liquid 
h1·. ving an unpleasant penetrating odor and a disagreeable 
taste. It is soluble in cold water to a ~reater degree, 
than in hot water. It mixes freely with vegetable or 
m1neral oil. It freezes at a comparatively high temper-
ature with formation of a white solid. Accordtng to 
Cushny, ('72) paraldehyde is a polymer of ethyl-aldehyde, 
resembles alcohol in its effects, though it is a much 
more powerful narcotic, and rarely induces any symptoms 
of excitement. It does not effect the heart directly, 
even in large doses, and has no such effects on the protein 
metabolism as hf, s been observed under the prolonged use 
of chloral. The pulse is slightly slower and the carbonic 
acid exhaled is less than normal. These changes, however, 




hardly greater in extent than the changes that occur in· 
nr: tural sleep. ( '72) According to Noel, ( '72) very large 
quantities have been t[;ken without fatal results and in 
fact without any more serious consequences than prolong-
ed unconsciousness. 
Paraldehyde h•- s been extensively used as a hypnotic 
and sedative, especially in the treatment of acute alco-
holics and for controlling the violently insane. It is 
commonly stated to be the safest hynnotic known. (110) 
It acts first on t-he cerebral centers and later on the 
lower parts of the nervous system. It has no deleterious 
effects on the circulation, respiration,. blood pressure, 
or metabolism. It is excreted unchanged, lar~ely through 
the lungs but partly bv the skin and kidneys. The renal 
effect is a mild diuresis. There are no known subsidiary 
effects on the functions of other organs. 
Dr. George A. Elliott, (110) formerly of Butler 
Hospital, now at the Connecticut State Hospital at Middle-
town, has made an intensive study of blood chemistry 
.following the intravenous injection of pllrEtldehyde. He 
injects from six to nine c.c. of pure paraldehyde as an 
anesthetic for minor operations. Paraldehyde is itself 
a powerful antiseptic ~;_nd ne2d not be sterilized. 'l'he 
anesthesia appeared almost im~ediately and lasted for 
several minutes, long enough for dental extractions and 
various minor operations. There was complete relaxation, 
some fall in blood pressure and some resniratory depress-
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ion. The blood was tG-ken for chemical examination a hHlf 
minute after the injection and at intervals during the 
next twenty-four hours. Blood sup;ar was undisturbed, 
Non-nrotein nitrogen was unaffected. Creatinine was also 
1_mchanged. The coagul< tion time was reduced from an 
average of three minutes to ninety seconds. 'l'here WbS 
no bleeding after dental extractions, a pulmonfry hem-
orrhage frequently could be checked, and hemorrhap.;e from 
a wound of the hand ceased after oral administration of 
pnraldehyde. 
The hypnotics vary in efficiency and in safety. They 
vary in effect on conscious perception, on reflex <tcti vi ty, 
and in their relief of pain. Pure hypnotics, as barbital, 
produce sleep. Sedatives, as ·nr;raldehyde, in addition to 
their hypnotic action, have a powerful an effect on relief 
of pain that t' 1 eir analgesic action overshadows their 
hypnotic effect. The immediate result of the administrat-
1.on of a narcotic is often stimulation rather than sedat-
ion of reflex activity. In some subjects, therapeutic 
dosage of narcotic relieves pain but has no hypnotic nor 
sedative action. On the other hand, administration of a 
pure hypnotic in the presence of severe pain wi11 usually 
not result in hypnosis, but in a state of active delirium. 
These considerations indicate that narcotics are not ideal 
pre-anesthetic h'rpnotics and that the pure hypnotics are 




Noel, (72) h&s the following method of administrating 
paraldehyde intravenously. Starting at fi 1"st with small 
doses, 4. c.c. of the pure dru~ were injected into a vein. 
Almost before the syringe was empty the patient was uncon-
scious. He slept naturall;"r for about two hours. Sub-
sequently 8. c.c. were injected with sat:tsfactory results. 
It was found, however, that the pure drup; caused a certain 
amount of locrl discomfort and coughing, and it was there-
fore diluted with saline to form a lO;'t solution. One 
hundred c.c. of this solution produced in about 40 seconds 
an anesthesia lasting about twenty minutes, and suitable 
for mi_nor suro:ical procedures. Paraldehyde, while acting 
temporarily as an anesthetic, had a prolonged hypnotic 
effect, considerably reducing the amount of ether sub-
sequently required. Being volatile, it was rapidly ex-
creted by the lunas, and this, says Noel, (72) is an 
imoortant element jn the safety of the drug, and an ad-
vantage which could never be claimed for the use of hedonal. 
In comparison with avertin, paraldehyde has less 
effect on conscious perception and memory, less effect in 
relief of pain but a greater depression of reflex activity. 
(110) The pc.raldehyde patient may come to the oper1tion 
apparently conscious and responsive to painful stimuli but 
will develop muscul~r relaxation in the presence of severe 
oper£:tive stimulation under a very small dose.ge of the 
aneethetic. Paraldeh'!de does not depress the respiration, 
does not affect the blood pressure or metabolism. It is 
{0. 
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~enerally conceded that it is without effsct on the liver 
and kidneys, and does not influence blood chemistry. It 
has a marked hemostntic effect. In comparison with e.vertin 
the margin of safety is very great, and the expense is 
almost negligible. (110) 
In comparison with morphine, paraldehyde is a power-
ful sedative but is inefficent in analgesic action. It 
does not depress the respiratory center and does not 
stiIIn.llate the vomiting center. It does not abolish the 
urotective cou~ning reflex, and it does not check secret-
ions nor diminish the flow of ur:t.ne, on the contrary, it 
is a mild diuretic. In comoarison wlth morphine, paral-
dehyde has a very great margin of safety. 
Paraldehyde is an efficent pre-anesthetic hypnotic, 
showing a minimum of deleterious effects upon the organs 
of the body and their functions. Its margin of safety is 
several times as great as that of morphine or avertin, 
but less than tho:...t of the barbiturates, and for thct 
reason, with the introduction of the barbiturates, it .was 
soon dropped from clincal use, in favor of the more bene-
ficial advontages f011nd in the use of the barbiturates. 
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BA..'RBITUR1~TES IN GENERAL 
For years the medical profession has looked forward 
to the nossibility of ::, drug that would numb the sensor-
ium and make the patient oblivious to his surroundings 
and yet not act in a deleterious way on any of rhe vital 
organs. Thierfelder Hnd von Mehring, (99) in 1880 made 
the observation, which was later confirmed by others, that 
the sleep producing action of alcohol was related to the 
number of ethyl groups present. A few years later, 
Schmiedeberg conceived the idea of producing a nitrogen 
containing hypnotic, knowing that intravenous injections 
of ammonia preparations raised the blood pressure. Then 
Schmiedeberg succeeded in preparing urethane; and, follow-
ing in the order named, pE,_raldehyde, amylene hydrate, 
sulphonal, trional and chloroformamide were produced. 
It was then observed that the intensity of the hyp-
notic action of sulphonal depended upon the number of 
ethyl rsdicals linked to a centrHl carbon atom, and for 
this reason Fisher and von Mehring, (99) in 1903 success-
fully completed the synthesis of a nitrogen-containing 
compound. This substance was prepared by treating di-
ethylmalonic acid ester with urea and sodium ethylate. 
The preparation was placed on the market under the name 
of "veronal", the generic name of which is "barbitaln. 
Since thr..-i. t time a large number of barbital derivatives 







in the substitution of one or both hydrogen atoms by 
other radicals. It is possible to develop a great 
number of these substances. 
In 1924, Fredet and Perlais, (99) two Frenchmen, 
succeeded in inducing general anesthesia with the barb-
ituric acid series. They used a mixture of di-ethyl 
allyl-barbiturate (trade name "somnifene"). This was 
administered intravenously. In 1927, Bumm, following 
the lead of Fredet and Perlais, used a barbituric acid 
derivative intravenously. This compound he believed de-
composed more readily than somnifene. He utilized sodium 
sec-butyl bromopropenyl barbiturate, (trade name is 
"pernokton"). He believed that the elimination of the 
pernokton W!:iS more rapid in the body .•;nd would permit a 
more rapid recovery from the anesthetic than would be 
possible with the other nreparation. 
In 1926, Page and Coryllos, (63) used sodium amytal, 
sodium iso-amyl-ethyl-barbiturate, to nroduce general 
anesthesia in animals. 
All derivatives of barbituric acid have certain 
characteristics in common which have long been recognized: 
1. They are primerily hypnotics; only occasionally will 
amounts ordin·rily producing hypnosis produce analgesia or 
anesthesia. Sufficiently lar~e amounts will induce anal-
gesia and anesthesia in both animals and man. However the 
dosage of such amounts precludes their routine use in 







effects observed with a given amount in the same or diff-
erent patient. This variability of action has made it 
difficult to select the proper dosage. 3. The amount 
required to produce a given therapeutic effect bears 
ap:oroximl,_tely the same relationship to the fatal dose in 
each of these various compounds, in their climtcal applic-
ation. 4. All members of the barbituric acid series may 
depress the respiratory and circulatory systems when 
amounts large enough to produce deep hypnosis are admin-
istered. 5. Comparatively large amounts of any of the 
derivatives of barbituric acid may produce hallucinations, 
and so forth, when the amount excreted or destroyed reaches 
a certain level. 
Zerfas, (64) points out that derivatives of barbituric 
acid have many characteristics in common, but differ largely 
tn toxicity, and rate and manner of elimination. Lundy, (87) 
has recently m&de an exhaustive review of the literature 
on this subject. The therapeutic mar~in of safety, based 
on experimental animal work, has been determined for a 
great many of these compounds. In clinical medicine we are 
interested to know the proportion of the fatal dose that 
will be required to produce a given effect. For all 
practical purposes that relationship is about the same for 
all the commonly employed derivatives of barbiturlc acid. 
Diethyl-barbituric acid, (barbital) is frequently cited as 
being the least toxic of these compounds, mainly because 
the amount required to produce death in animals is relatively 
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large. Should one desire to produce a given effect short 
of the frtal dose, the amount of barbital required would 
bear about the same relation to the fatal dose as that of 
a compound considered two or three times as toxic. Should 
subsequent sub-lethal amounts of barbituric acid be given 
before the en+ire amount was eliminated each time, barbit-
al would ultimately prove decidedly more toxic than those 
compounds eliminated or destroyed at a faster rate. 
Fitch, and his associates, (95) state that there seems to 
be little advantage that can be claimed clinically for the 
intravenous use of one barbiturate over another, except in 
so :far as the advantage lies in differences in duration or 
depression and in the total quantity of the drug that the 
organism must destroy or eliminate. 
According to Friedlaender, (67) most of the barbit-
uric acid derivatives such as ve»onal, amytal, allonal, 
ipral, luminal, noctal and pernocton have been tried out 
experimentally and clinically and their action bas been 
similar in the human being and in animals; namely, as 
sed1:tives, analgesics, or hypnotics, depending upon the 
amount administered. The toxi·c reacttons of :tndi viduals 
to the various barbituric acid derivatives are essent-
ially the sr;.me, with the exception of pernocton and 
noctal. 
The use of the derivatives of barbituric acid as 
an·esthetics ond hypnotics has been closely studied in 
the last few years, especially in the United States, and 
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the literature is now extensive. (66} Lundy, (85) quotes 
no fewer than 466 references. As regards the use of the 
barbiturates in human surgery, one may draw the following 
conclusions: (95) 1. The employment of a barbiturate as 
the sole anesthetic is inadvisable. 2. As basal hypnot-
ics the barbiturates are among the most valuable drugs 
available. 3. The suitability of a barbiturate as a 
bcsal hypnotic depends largely upon toxicity, and short-
ness of action. The i;;reater the toxicity the smaller is 
the dose required, and the smaller the amount of the drug 
to be detoxicated or eliminated. 
The barbiturates cE.m he aa.m-~nistered j_n one of two 
ways, either by mouth or intravenously. The former route 
has the advantage of simnlicity, but Hccurate dosage, which 
is essential for successful anesthesia and which varies 
with each individual patient, is difficult to obtain. The 
intravenous method is commonly employed, because it allows 
the minimPl effective dose to be determined accurately. (69} 
With this, a solution of the chosen drug is injected at a 
predetermined raf-e, ceasing when consciousness is lost. 
The duration of administration varies according to the 
toxicity of the drug employed; it is shortest with Pernocton 
and longest with Amytal. (69} A warning, however, was 
issued by the Council of Pharmacy and Chemistry of the 
American Medical Association, regarding the intravenous 
administration of barbiturates. It is stated that these 
comriounds require large amou.nt s of alkali for solution; 
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amytal, for example, requires a de~ree of alkalinity the 
equivalent of a buffer solution with a pH of 9.5, and 
therefore this drug, and for that metter any other barb-
iturate, will not remain in solution with the chemical 
reaction of the blood. (69) The comoound is orecipitated 
and then there is a foreign body, in the colloidal state, 
within & sensitive colloidal system,--narrely, the blood, 
whose physic-chemical properties rnd physiologic.el 
f1.mctions are unintentionally and undesirably affected. 
R.C. Garry, (69) states that this action, which is not 
peculiar to the barbiturates, is probably responsible for 
certain reflex effects :'rising either from the disturbed 
colloidal equilibrium of the blood or from marked alkalin-
itv of the injected solution, or both. These intravenous 
reflexes which may be invoked by irritation of the depress-
or nerve endings or of the vagus nerve terminations in 
the viscera, and which result in sudden circulPtory end 
respiratory disturbances, are unnecessary and undesirable; 
they complicDte the ordinary hypnotic action of the barb-
iturates, and submit the uatient to additional risk. 
In view of these facts the Council of Pharmacy and 
Chemistry maintains that any advantages thet can be pro-
cured by giving Barbiturates can be urocured by giving 
them by the mouth; and that, in the present st&te of know-
ledge, the intrr-_venous route should be reserved for only 
emergencies and for those cases in v(r:ich oral administrat-
ion is physically impossible. The wisdom of this attitude 
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is ~enerally recognized, for, although it is not in harmony 
with the favoreble opinions, based upon clinical invest-
i~ation rather than upon pharmacological experiment, origin-
ally entertained regarding the intravenous administration 




One of the most recent derivatives of veronal is 
amytal (iso-amyl ethyl.barbituric acid). This drug was 
first described by Shonle and Moment (62) in 1923, and 
wi s promptly used by Page, (63) in pharmacological ex-
perimentation. At first the difficulty of preparing the 
soluble sodium salt of amytal delayed the use of this 
drug as an anesthetic for human beings. Very recently 
however, the presence on the market of the sodium salt 
of amyt['l in stable form has permitted its wide applic-
ation as an anesthetic in man. (64) A full description 
of the clinical use of the barbituric acid ~roup of drugs, 
both in surgical and in non-surgical cases, may 1-·e found 
in the Proceedings of the Staff Meetings of the Mayo 
Clinic. ( 85) 
Intravenous administration of a 10% solution causes 
a very rto.pid onset of anesthesia, but the injf'ction must 
be carried out very slowly, because of severe circulatory 
disturbances. In man, 20-25. mgm. ner kilogram of body 
weight is sufficient for complete surgical anesthesia, 
and 12.-20. mgm. per kilo~ram of body weight is adequate 
to lower the dose of such volatile anesthetics as ether, 
or nitrous oxide and oxygen, to t of the usual amount 
required. (85) Stormont, Lampe, and Barlow,. (86) working 
on rats, showed that premedicatlon with amytal or other 
barbiturates permitted the nroduction of full nnesthesia 
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with a lower percentage of nitrous oxide and a higher 
percentrge of oxygen than is usually necessary. 
In man there is a post-anesthetic sleep, and drowsi-
ness, governed by dosa~e, for 12.-72. hours. This con-
siderably increases the necesPary nursin~ attention. 
Neither in animals nor in man are there si~ns of post-
operative distress. (87) The statement b;r early workers 
that carbohydrate metabolism is unaffected by amytal, 
made this dru.P.' the anesthetic of choice during the wave 
of experimental investigation into carbohydrate metabol-
ism which followed on the discovery of insulin. This 
swee:oing claim for amytal as a true nphysiolorr,ical" 
anesthetic has not stood the test of time. Glucose in-
jected intravenously is not removed from the blood at the 
usual rate, presumably due to inhibition of the storap:e of 
glycogen in the liver. (88) However this may be, there 
seems to be a general consensus of opinion that amytal 
anesthesia has a less disturbing effect on carbohydrate 
metabolism than the majority of other anesthetics in 
general UEe. This may be not without significance in 
anesthesia in man if damage to the liver is feared. 
As is to be expected, amvtal lowers the body temp-
erature, certainly by enforced inactivity and possibly by 
a direct depressor 'Ction on metabolism. All barbituric 
acid derivatives are respiratory sedatives. Amytal, how-
ever, in anesthetic dosage, does not greatly diminish the 
mlnute-volume of respiration, and the respiratory center 
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remains sensitive to carbon dioxide. (89) Amytal has a 
definite toxic action on the heart, and this is more mHrk-
ed the more rapid the adminis+ration. (90) For this 
ree_son rapid intravenous exhibition of the drug is fraught 
with di:mger. The blood pressure falls rapidly, and one 
hour or more may elapse before it regains its previous 
level. This fall in blood pressure is due both to dilat-
ation of the heart, with reduction in minute-output, and 
also to vase-dilatation. (91) Large doses administered 
rapidly may cause heart block, ventricular fibrillation, 
and death. In clinical use, amytal lowers the systolic 
and diastolic pressure, and this fall in blood pressure 
may be alarming if the administration be rapid. (85) 
Because of the great controve!'sv over the use of amytal 
in Obstetrics, the following information may throw some 
licri1t on the sub,ject: in vitro, amyte.l, even in h5_gh 
concentration, has no effect on the movements of the 
guinea pig uterus, 1::1nd the response to "pitocin", is 
unaffected. (92) Amytal has found great favor and has 
been used successfully ln many obstetrical clinics. 
Barbituric a6id derivatives do not all react in the 
same way; they are excreted in variable amounts and with 
variable speed. Amytal does not anpear as such in the 
urine of dogs, whatever the route of adrY·inistrstion. (93) 
There seems to be no detrimental effect on the kidneys, 
and like other aneEthetics, amytal inhibits water diur-
esis. (94) The known effects of amytal on laboratory 
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animals are correlated with the more recent experiences 
of amytal as an anesthetic in human beings. Although 
amytal his been definitely disappointing as an anesthetic 
in physiological research work, yet, when pronerly used, 
its ph~;rmacological actions may be of no hinderance to 
its use as an anesthetic in man. (84) 
The effects of sodium amytal on the circulatory system 
are somewhat dependent on the 8mount, rate, and manner of 
administerntion of the drug. It is possible by the rapid 
intravenous injection of sub-lethal doses of sodium amytal 
ln animals to produce death or an immediate fall in blood 
pressure to alarming levels. Lieb and Mulinos, (97) 
state that sodium amytal when given intravenously to 
laboratory animals, depressed the circulation and produced 
a prolonged temporary parB.lysis of the vagus to the heart, 
which lasted from one to one and a half hours. Shafer, 
Underwood, and Gaynor, (98) have conflrmed these fj_nd~rw,s 
reported by Mulinos. Tht::y also four,d the p;reftsst slowing 
from stir:mlation of the vngus ; n decerebr.s.te animals and 
the least in those just under arnytal, while intermediate 
slowing was observed in dogs under ether. The blood 
pressure incre:-ised following stimulation of the vagus 
under amytal, Jf the vagus car1"ied a ;;;reater number of 
pressor impulses. Lundy, (87) and others have observed 
an incre:· se in blood pressuJ•e in two cases following 




As a rule, following t.he intravenous injection of 
sodium amytal in man nt a compar&tively slow rate, one 
c.c. per mlnute, a decrease in both the systolic and the 
diastolic blood pres!"ure occurs, usu&lly durinr; the tlme 
the drug is being injected, and hecomes most marked when 
the patient loses consciousness. Mason, Baker, and 
Pilcher, (99} reported that the systolic pressure in all 
but a few instances fell to an avera~e of 30. mm. of 
mercury, and the diastolic to an averap:e of 15. mm. 
durinp; the induction of anes'hesia, but: returned to normal 
levels early in the operation. Patients with hypertension, 
those who are m2rkedly sclerotic, and patients who are 
debilit8ted from chronic illness, may show much greater 
decreases in blood pressure, even to alarminp; levels and 
subsequent death. 
James Poe, (5'7} states that because of the possibility 
of a greut fall in blood pressure, elderly patients with 
~eneral arteriosclerosis and hypertension are considered 
unsatisfactory subjects, &s the fall in blood nressure 
may have serious consequences, and hence the dose should 
be very much lim~_ted, if used at all, in these cases. 
Animals given fatal doses of sodium amytal died of 
resnirEtory failure, which usually precedes that of the 
circulatory system, though failure of both sometimes 
occurs simultaneously, particulrrly if the drug is in-
jected ranidly. Isenberger, (89) in a series of exper-
iments on animals desi~ned to show the effect of narcotics 
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on the function of resDiration, found that moderate doses 
of sodium , m:rtal resulted in a slight decline in the rnte 
of respir&tion accompanied bc- a compensatory increase in 
denth. Small doses of morphine ~iven prelimin~ry to 
sodium amyt~·-1 seemed to render the action of sodium amytal 
more uniform as well as more 1ntense, and thus reduced the 
amount of both sodium amytal and morphine required. 
Isenber~er, (89) also calls attention to the fact, however, 
that morphine may be chiefly responsible for the changes 
in the respiration observed after morphine and sodium 
amytal have been given in sequence in therapeutic doses; 
also, that basal narcosis, as a result of the proper ad-
ministration of sodium amytal in combination and sequence 
with morphine preceding the administration of a generf•.l 
Hnesthetic, such as ether, and full surgical anesthesia 
with relaxation, were safely and easily established and 
adjusted. At the s&me time, the-r>e appeared to be retain-
ed a definitely higher degree of respiratory reserve than 
when ether alone, or ether preceded by morphine Hlone, 
was used to a stat,e of similar degree of anesthesia and 
relaxation. 
Clinical observation of the administration of compar-
atively small amounts of sodinm amytal for pre-anesthetic 
preparation of patients h~ s been described, and follows 
closely that defined for animals. The respirations ~:.re 
usually regular in rate, but are frequently reduced 1.n 
amplitude. There w0 s little che.nge in t:he color of the 
skin, although a sJight degree of cyanosis has been noted. 
Mason, Baker and Pilcher, (99) call attention to the 
development of a flush of the skin, sometimes resembling 
a febrile reaction. 
When the drug is injected intrf1venously the induction 
of sleep is rapid and quiet. Drowsiness,.noted by droop-
ing of the eyelids, yawning, and slurring; of words, comes 
on after the administration of 3.-9. grains. These same 
authors also noted that as the dose was increased the 
oat:Lent became reflexly hypersensitive, and finally enter-
ed a profound state of narcosis. The pupils became con-
trFcted and in some cases fixed, so that they would not 
rec:1ct to light. The corneal reflex was diminished and 
the gag reflex remained intact. The knee jerks were often 
exagQ:er< teu during the period of hyperesthesia. In this 
state, patients sometimes became restless, if stimulated. 
The period of unconsciousness may last anywhere from 
3.-6. hours, depending U 1)on the amount of the drug given. 
,!!hen a sufficient amount of the drug was eliminated or 
destroyed, the patients passed through a mildly restless 
period of comparatively short durrtion, in which they 
were disoriented, moved aimlessly about, and uttered in-
coherent statements. During the followin~ hou~s they 
continued to be drowsy, and slept at intervals. 
L.G. Zerfas, (64) states, "in our earlier work, we 
used sodium amytal in apnroximately 100. cases as the 
sole anesthetic. It was soon apnarent that the mi:irked 
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depression upon the circul.,tory and resniratory systems 
carried with it certaln dangers wh 1 ch would not warrant 
its ~eneral use. The ~reater pronortion of the patients 
were restless and delirious for a period of time, which 
added further to the difficulties of its employment es 
an nnesthetic agent. Also there were no clean-cut 
criteria for judging the dosage when adm1nistered in such 
amounts 11 • This drug and other barbituric acid derivatives 
have been employed in smaller doses to a definite advantage 
in the nre-anesthetic preparation of the patient. 
Holman and Palmer, (100) state that the occasional 
pestlessness and the mild delirium after operP.tion are a 
definite disadvantage, but are usually absent when amytal 
is administered in smaller doses, ri:-lnging from 7.-12. 
~rains. In their experience with the intravenous admin-
istration of the drug the drop in blood pressure is a 
distinct disadvantage. Even with small doses this drop 
may be alarming, and may be sufficient to warrant post-
ponement of the operation. They think it ma~r be an evidence 
of an individual idiosyncrasy to the dru~, and its 
possible appearance makes frequent observations on the 
blood pressure during the administration of the drug 
imDerative. They conclude from their experiences w~th 
:tts use in 150. cases of q:eneral surgery, that sodium 
amytal provides the normal :1nduction of a natural sleep 
without the apprehensive struggling of a conscious patient. 
There was noted a marked reduction in the postoperative 
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nausea, struggling, and pain. In operations upon nr,tients 
with exophthalm.ic goiter, and upon very apnrehensive, 
excitable p~~tients, sodium am:ytel h~,s, they believe, a 
very definite place in anesthesia, and may be used in 
doses of 7.-12. i;i:rains with definite advantage to the 
patient. 
Mason and his associates, (99} using sodium a.mytal 
intravenously, called attention to the variation in 
individual susceptibility to the drug. They found that 
the minimum dosage required barely to erHse consciousnes~ 
varied frequently from 3.-9. ~rains, illustrating the im-
practicability of estimating the proper dosage. From their 
experience with its use in 305. cases, they concluded that 
when the drug was used for the pre-anesthetic preparation 
of the patient, with a dose just large enoug;h to make the 
patient lose consciousness, it gave: more satisfaction than 
any other drug used. In patients with hyperthyroidism, 
Pnd in those who were nervous, it g;ave the most satisfy-
ing results. 1fuen the drug was given slowly and the ad-
m' nistration stopped as soon &s the petient lost conscious~ 
ness, they considered that no serious or untoward effects 
would be experienced. They sugg;est the followi"g surgical 
indications for its use: hyperthyroidism, and lrparotom-
ies in which jt is desirable to have relaxation with 
ethylene; kidney operations, nslng sodium amytal supp-
lemented by ethylene; to produce unconsciousness where-
ever there is an emotional element of any degree before 
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any type of operation; for the control of postoperative 
delirium or excitement; and as a pre-operative measure 
to promote rest in hi~hJy toxic goiter cases. 
The uses of this drug for purnose s other thf·in pre-
anesthetic preparation of the Datient, include the control 
of convulsions as observed in tetanus, eclampsia, status 
epilepticus, strychnine poisoning, and cocaine and pre-
caine poisoning. It has also been used in controlling 
patients with delirium tremens, unmanageable mental cases 
and various postoperative psychoses. 
In the field of anesthesia, patients who are poor 
anesthetic risks lll1lY be considered "1oor risks when sodium 
amytal is used for ':ire-anesthetic preparation. Patients 
with hypertension, hypotension, generalized arteriosclerosis 
and those who are emaciated are poor subjects for the use 
of sodium amytal. Patients with pulmonary infections, 
lung abscesses, and bronchiectasis should not receive 
enouP:h of the drug to interfere with the gag reflex, and 
it is better o~ the whole to use very small amounts, 3.-6. 
grains, preferably without producing a total loss of 
consciousness. The drug should also be given cautiously 
or not at all, following very large doses of morphi.ne, or 
in those patients particularly sensitive to morphine and 
similar drugs. The intrav~nous administration of the drug 
should be stopoed at once if an acute drop in blood press-
ure or a mhrked decrease in the hmplitude of the respirat-
ion occurs. The intravenous method cHrries with it certain 
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disadvantages, such as the dangers from too rapid ad-
ministration, more ac1 te respiratory and circulatory de-
pression, and the technical difficulties and dangers 
inherent in intravenous administration of drugs. However, 
the effects are obtained almost immediately; the minimum 
amount required for the individual patient may be judged 
more accurately; and the rate of elimination or destruct-
ion proceeds at a faster rate. As is well .known, no fix-
ed rule can be used for calculatinp.; the dosage, and 
individual variations exist in man. This one point alone 
is sufficient to contraindicate t.he use of barbituric acid 
derivatives in large doses. It is considered, however, 
that doses of 3.-9. grains, not exceeding 15. ~rains, are 
comparatively safe limits for the clinical use of sodium 
amytal. ( 84) 
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PERNOCTON 
The desired qualities in obstetrical anesthesia are 
those of general anesthesia with important additions. 
These additions are: 1. The anesthetic should not interfere 
with uterine contractions; 2. If possible, it should per-
mit reflex abdominal muscle contractions; 3. It must not 
effect the foetus. It was the search for a drug that 
would fill the above prerequisites that led to the dis-
covery of the barbiturate called pernocton, and until the 
advent of pernocton, it could not be said that such an 
anes•-hetic, with the partial exception of nitrous oxide, 
existed. 
The extent of anesthesia is determined by the con-
centration of the anesthetic in the blood and tissues, 
and the appropriate concentration is such that the 
cortical cells are depressed, but the medulla, with its 
resniratory and cnrdifJC centers, is not so affected. {68) 
Pernocton is a 101& solution of the sodium salt of second-
ary butyl-B-bromallyl barbituric acid. It is a white 
crystalline substance soluble with difficulty in water, 
but readily in alcohol. 
Animal experiment has shown that acetonyl barbituric 
acid is the fragment of the pernocton molecule which is 
excreted in the urine, and this renresents only one-fifth 
of the amount administered, that is, the remainder is 






with acetyl acetonyl barbituric acid with the result thet 
only a small portion can be recovered from the urine, 
pointing to the fact that the molecule can be oxidized 
by the o~ganism. (68) 
The chemical formula of pernocton is CllH140~N2BrNa. 
It was in•·roduced in E.urope and has been extensively used 
there during the last ten years. It has also been used 
recently in this country in both s 11rr:ery and obstetrics 
with good results. It apnears to have an advbntage over 
the other bnrbiturBtes bec&use of its early detoxication 
within the body, and hence is without the prolonged sleep 
and depression that so often follows the use of the other 
hvpnot:.c drugs of this type. Pernocton has also the ad-
vantage of stability when in solution and hence is pre-
pare.l in a sterile solution, ready for immediate use. (57) 
Pernocton has been in use in GermErny since 1927. ( 58) 
Its advantage over sodium &mytal and nembutal is thr>t it 
is st&ble in solution so th1::it no mixing or dilution is 
necessary. 
Pernocton, by the introduction of the -CH2-CBr=CH2 
group, acquires one of the most desirEble attributes of a 
good hypnotic, the nro;:erty of ranid decomposition or 
Rlteration to non-toxic substances within the tissues. 
Ac~ording to R.F. Matters, (68) one of the most signif-
icant structurhl l:idvEintages is the presence of the sec-
ondary butyl radicle which by its asymmetric carbon atom 
61. 
sinmlates naturally occurring molecules. The toxic margin 
with P.ernocton is very high; intra venous admi ni strf;tion to 
rabbits gives a ratio of 1: 10 for fl v·erage narcosis dose. 
Intravenous adm:tnistration is desirable in that it 
admits of absolutely eccurc;.te dosage and rate of absorpt-
ion by the nerve cells. Intr&muscular or enteral admin-
istre.tion is uncertain in this respect and, although 
necessary when more dangerous compounds are used, it is 
not important in pernocton anesthesia, except perhaps for 
additional amount which are given intramuscularly mainly 
because of the slower absorption. (68) 
Its initial use was tried in asylum nractice, and 
the first clinical knowledge of its value is due to Bumm, 
head of the Surgical Clinic at the Charite, Berlin, 
Germany. (Taken from R.F. Matter's report, (68)) Bumm's 
first review of 100. cases begins the literature upon this 
subject. Since then, 1927, until April, 1930, two hundred 
thousand cases of clinical administration have been report-
ed. In giving pernocton, it is very necessary that one 
should induce by suggestion a satisfactory mental attitude 
in the patient. The dose of pernocton is 1. c.c. per 
12.-15. kilograms of body weif!,ht, the rate of injection 
being 0.75 c.c. per minute. 
The method of administration now most uni versE.lly 
adopted was originally taken from a pB.per by Brammer, of 
the Universitats Frauenklinik, Freiburg im Baden, whose 
1500. pernocton deliveries have been completed and of 
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these he has esnecially analyzed 225. cases to determine 
the best procedure. In the s1:tme paper is given a minute 
analysis of the results of pernocton anesthesia as used in 
other clinics, and he indicates especially the following: 
(taken from R.F. Matter's discussion of the original paper 
in German, #68) "Goldschmidt states th£lt 3.5 c.c. is the 
lowest amount that suffices for a case. Vogt uses 8.8 c.c. 
as an initial intravenous injection, and after 45. m5nutes 
gives 4. c.c. intravenously, in addition. He soys there 
are no ill effects. Mutz gives 3.5 c.c. intravenously 
and 1.5 c.c. intramuscularly. He says that anesthesia 
lasts for three hours." Brammer states that using 5. c.c. 
of pernocton, it was found that the intravenous route was 
many times more efficacious than the intramuscular route; 
he considers that the latter has a variable rate of absorpt-
ion. He further advises that in primiparae the pernocton 
should be given when the os is "five shillings" dilated; 
the cervix in multiparae should be dilated only "three 
shillingsn. The averaP::e duration of the "twilight sleep" 
for the sin~le dose in 72. women was found to be 2.5 
hours, e.nd the average duration in 28~ was 1.45 hours. 
In 801 of Brammer's cases the anesthesia ll:isted for 3. 
hours and the &mnesia was complete. 
Matters ( 68) makes the following conclusions:, 1. 
Pernocton is a suitable obstetrical anesthetic; 2. It 
has been abundantly tried and fulfills all the require-
ments of obstetrical anesthesia; 3. The results he 
·..__ ........ 
obtained corresponded closely with those published in 
Europe; 4. Quiet surroundings and careful suggestion 
're essential to the technique; 5. The intravenous 
route is the more exact and suitable method of injection, 
while the more slowly absorbed intramuscular injection is 
used for additional doses to maintain the concentration of 
the anesthetic in the blood. 
Friedlaender, (67) states that the psycholog:lcal ex-
planation of sleep ls the theory which best lends itself 
to an explanation of the action of pernocton. As will 
be shown later, the method of ~iving pernocton includes 
preparation for hours, even days before the advent of 
the operation. The patient is prepared by sugp,estion 
for what to expect and is told how pleasant and harmless 
pernocton is. This suggestion as a preliminary is very 
essential, for it induces a state of mind which is the 
first step to beneficial sleep. (67) 
Pernocton directly paralyzes the receptive ab5.lity 
or rather the ability to synthesize ideas and impressions 
and thus nroduces narcosis. The narcosis induced by this 
drug is one sten beyond natural sleep, for the individual 
cannot be roused by ordinary stimuli. Pernocton is described 
· bv some as a paralyzer of the ability to concentrate on 
limited number of stimuli. Pernocton belongs to the ~roup 
of hydrocarbons, all of which possess the ability to pro-
duce naroosis in varying degrees of toxicity and effect-
iveness. As a general rule, "all other factors being 
------------.... 
64. 
equal, the effectiveness of action of a hydrocarbon in-
creases with the len.!:1'.th of the chemical side-chain. 11 ( 6'7) 
A limit to this rule is soon reached, for the longer the 
side-chain, the less volE tile, soluble, and absorbable 
the drng becomes. It can rePdily be seen that an insol-
uble, non-volatile, and non-absorbable drug, no rratter 
how powerful it is, is of no use. 
Pernocton has an especially effective len~th to the 
side-chain; not too long as in amytal, where the variat-
ion in solubility of different lots is due to the excess-
ive length of the side-chain. Another factor enhancinr: 
the value of pernocton is the halogen replacing one of 
the hJ[d:r:pgen a toms. ( 6'7) Bromine supnli es all of the 
benefits of the halogen, at the same time lacking all the 
danirerous qualities of the other halogens. In short, 
pernocton, according to its advocates, contains all the 
factors making for therapeutic effectiveness and has no 
determinate qualities such as undue toxlcity or difficulty 
of manaci:cment. 
This is really highly debateable and only the opj.nion 
rendered by those who champion the use of pernocton. The 
reletively slight toxicity of pernocton as compared with 
the other barbitu.rates is due to the rapid decomposition 
of the drug in the body. This same author, (67) who so 
strongly champions the use of pernocton, also made the 
followin~ statements wh-ich have a bit of a contradictory 
air to his previous conclnsions: "From the beginning of 
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our investigations we had in mind the two main factors, 
ease of control and harmlessness on one hand, and pre-
servation of the patient's constitution on the other. 
Because these two factors were not found in an;r one of 
the anesthetics known today, we sought for and obtained 
the desired results by combining pernocton with an in-
halation anesthetic, preferably ether." {67) 
Pernocton's use, therefore, is principally that of 
basal anesthesia, or an induction medium, followed by 
ether. With this combined anesthetic, somatic sensibil-
ities Are to a ~reat extent eliminated. Complete anesth-
es:ta with pernocton is never attempted by the wise, states 
one author. The determination of the proper dose depends 
upon the wei~ht and the psychic condition of the natient. 
As a rule, 1. c.c. of the 10~ solution of nernocton per 
12.5 kgrn. of body weight will be sufficient to put the 
patient into a deep sleep in from one to two minutes. 
Examinations too painful to the patient to be carried 
out without an'" sthesia, E.nd minor surgical operations crn 
be made under the influence of pernocton. The drug hrs 
been used in cases of ~eneral sur~ery, in operations upon 
the thyroid P,land, stom2ch, gall-bladder, appendix, 
kidney, prostate, etc. In 700. cases reported by Bernard 
Friedlaender, (67) there was not a s1ngle fntalitv, and in 
only 4. cases were there found an excessive a.mount of excit-
ability i'ihich vm s beli evsc: to L.~ Vi'0 bEH'ln duE to an improper 





The method for the intrHvenous injection of pernocton 
is as follows: 1. Pernocton is a hypnotic to be used 
intravenously. If used in ravenously 'in the nroper dose, 
instEnt sleep is produced with +-he elimination of all 
sensation; 2. Its principal use is for in&1ction and the 
supoort of an inhalation anesthetic and it serves to avoid 
all psychical disturbances of the putient; 3. The avera~e 
dose need not be more than 1. c.c. to 12.5 kilo~rams of 
body weight; 4. The intravenous injection should be 
stopped even if the full dose ha8 not been given; 6. In 
fifteen to twenty mlnutes after the injection, a small 
amount of ether may be ~iven to t:he patient by inhalat-
ion; ?. The normal sleep after oper&tion may last from 
two to five hours, reducing postoperative pain to a mini-
mum. 
The conclusions that I reached, after rending most 
of tne available data, which is enormous in amount, 
concerning pernocton and its use &re as follows: 1. 
Pernocton, in chemical structure, combines +-.he advantap;es 
necessary in anesthesia in the possession of « long side-
chain and a halog-en replacement of •-he hydrorr,en a tom with-
out sufferinR the disadvantages of similar compounds, 
namely, insolubility, toxicity, etc. 2. Pernocton pro-
duces a state closely rela~ed psychologically to natural 
sleep, wjth the fidded benefit of rendering the subject 
impervious to extern~l stimuli. 3. Pernocton should be 
administered in a dosap;e relative to the body weight. 
"" 
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4. Pernocton should never be adm;nif'tered in doses 
great enoui::i:h to abolish the reflexes. In major operations 
it should be used as an extreme hypnotic for induction, and 
combined with a small &mount of ether. 5. Pernocton may 
be used effectively as the sole anesthetic for painful 
examinations, and minor surgical operations, but the 
danger in this sole use of pernocton is great. 6. The 
700. cases with no fatalities and only 4. cases where 
extreme excitability was present are seemingly fair evidence 
of this drug's beneficient effectivity 
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NEMBUTI~L 
Nembutal, sodium ethyl methyl butyl barbiturate, has 
the characteristics of the barbituric acid series more 
clearly developed than any other barbiturate. It is 
about twice a.s toxic as sodium amytal, (96) and its 
action is much shorter. Lundy, (96) states that it is 
more sedative than hypnotic and thPt it causes delirium 
and restless-ness less often than other barbiturates. 
Nembutal (Abbott) is supplied in ampou~es (gr. 7i) for 
intravenous use after being disBolved in distilled water, 
10. c .c. 
For the inject.ton a 10. c.c. syrinp;e is used with a 
fine hynodermic needle, and the solution is injected at 
the r::..te of about 1. c.c. per minute. When administered 
intravenously the inject'ion need not be begun until 10. 
minutes before the time of operr:tion, for the effect is 
qujckly and accurately obtained. No calculation of dose 
on a body weight basis is necessary, the amount being 
determined by the progressive effect during injection. 
The solution should be freshly prepared and quite clear. 
The injection should be carried out &t the rate of about 
1. c.c. per minute, a close watch bein~ kept on the 
p:··.tient throughout. The patient's response to questioning 
becomes gradually more 2nd more indistinct and without any 
period of excitement, the patient p8sses into.a quiet 
sleep. The dose is the minimum amount necessary to 
produce this effect aft r:r slow and careful injection. 
The minimal dose in Magill's series of clinical cases, (66) 
was grains 3. and the maximum was grains '7i. When sleep 
ensues after intravenous injection respiration is quiet, 
diminished in amplitude, and normal in rate. It hi:is been 
stated by some that a fall in blood nressure takes place 
during the injection of a barbiturate, (85) but other 
exoerimenters such as Magill, (66) find that with nembutal 
the fall in blood pressure is trivial or absent in '11 
their cases. 
During the course of the operation after :i.ntravenous 
injection t.he amount of the sunplementary anesthetic re-
quired is less than with oral or rectal administration. 
This, says Magill, "is clearly the result of the more exact 
dosa~e by the intravenous route." And, perhaps it is due 
to this more accurate dosage that a survey of literature 
reveals that the post-operative effect following intra-
venous injection is more marked than with oral or rectal 
administration. Drowsiness or sleep from 1.-5. hours 
after operation is the usual course, with hazy memory for 
events dur:lng thb.t period. 
In order to compare the results obtained with other 
barbitur0tes, I.W. Magill, (66) administered sodium amytal 
intravenously to 23 cases, and pernocton to 15 uatients. 
All of these uatients were adults. Induction of pre-
onerBtive sleep with sodium amytal compared favorably 
with nembutal, but the recovery period was much longer. 
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Pernocton has heen reckoned eau;l to nembutal in toxicity, 
and the recovery neriod was about equal. (95) 
It is in the intravenous use nf nembutal that the 
gre~test advantage over other methods of administration, 
lies. By this method it is possible to determine the dose 
accurately during injection of the drug. Here, ap;&in, the 
reaction of the patient seems to bear little relation to 
age, body weight, or habits. Intravenous injection of a 
drug in connection with anethesia is open to criticism as 
an unnecessary complication not unattended by danger. If 
injection is carried out carefully and slowly, with asept-
ic precautions, it need involve little more risk, and 
certainly no more discomfort, than a hypodermic injection. 
From the adult patient's point of view, a prick with a 
hynodermic needle is usually expected before an operation, 
2nd to many it is more acceptable than the retention of a 
rectal injection of any kind. Intravenous injection of 
nembut&l is a vaila~le, f 1irther, 'Nhen rectal premedication 
is ruled out by the nature of the operation. It requires 
a minimum of ap-oaratus and preparation. The followlng 
might se,,..ve to summarize the subject: I. Intravenous 
injection of nembutal provides a pleasant method of 
bridging the gap between consciousness and unconscious-
n~ss, before general anesthesia. 2. The amount of 
anes; hetic subsequently required is diminished. ;-s. Post-
onerEtive nausea Bnd vomiting are diminished or 8bsent. 
4• The chief disadvantage is postopers~ive restlessness 
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in s. small percent<:ge of cases, about 10%. (95) 
It hbs recently been well established that there is 
great v~riability in duration of the sedbtive and hypnot-
ic actions of different members of the bbrbi turic acj_d 
series. As regards hypnotic action they have thus been 
arbitrarily divided into "long-acting" and "short-acting" 
barbiturates. Sodium iso-amyl-ethyl b1°rbiturate, (sodium 
imytal) is a ~ood example of the first, and nembutal may 
be taken as typical of the short-acting barbiturate 
hynnotics. 
In sur~ical cases experience of a good many has 
proved that a short acting barbiturate, having a brief 
hypnotic c.ction, is safer and more satisfactory than long 
acting barbiturates. In general, Volwiler, (59) says, 
the long acting barbiturates are antispasmodic and hypnot-
lc with a durable hypnotic action; the short actj_ng ba.rb-
i tura tes are antispasmodic and sedative with hypnotic 
2ction of short du:r'ation but of sufficient length to cover 
the ~eriod between administr&tion and the induction of 
surgical anesthesia as well as of the operation itself. 
In medic.:l cases, he points out, ~ short act:lnp; hypnotic 
ts often prefera.ble because the hypnotic effect is still 
long enough to assure hours of rest for the p~'itient, yet 
the nroduct is eliminated so rapidly that there is much less 
likelihood of "hangover", more commonly exoerienced after 
the long-acting barbiturates. Furthermore, the barbiturates 
of the short acting series are characterized bv the fact 
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that a smaller dose produces a very tntense if more fleet-
ing act:ton. This means a more rapid elimination ~nd a de-
creased tendency to any possible toxic or other undesir-
able effects, with a wider m1rgin of safety. 
'Nhile in laboratory animals r;eneral surp;ical anesth-
esia has been induced successfully by the employment of 
barbiturates alone, a resume of the literature shows that 
clinical attempts have not been uniformly satisfactory 
for the human subject. The general opinion of clinicians 
is that the barbiturates find their field of usefulness as 
hypnotics and as pre-anesthetic sedatives. 
A pharmacolo~ical report by Fitch, Waters, nnd Tatmn, 
(95) covered an accurate laboratory and clinical comparison 
of sodium amytal and nembutal, as well os the German prep-
aration, pernocton. These investigators, (95) found that 
to produce sleep in an ordinary previously morphinized 
jndividual, 0.6-1.4 grams of amyti;_l, 0.4-0.R grams of 
pernocton, and C.2-0.5 grams of nembutal were required. 
They also found th1- t both the period of postope:rative 
sleep and the postoper1.:J.tive excitation were distinctly 
less with nembutal than with the other two barbiturates. 
Dr. Johns. Lundy, (87) reported clinical confirm-
ation of the pharmacological observations of Fitch, 
1.Vaters, and Tatum. (95) Based on his observations on 
several thousand cases in the Mayo Clinic in which 
sodium amytal or nembutal were employed he found thnt the 




with lesfl delirium incident to its use than with the 
former. Moreover, it is twice as effective, thus per-
mitting smaller dosage, and the period of recovery is 
only half as long. Dr. Lundy, (87) concluded that the 
nembutal is particularly advantageous in obtaj_ning pre-
operative sedation regardless of the final anesthetic 
used and in cases in which it is desired that the barb-
j turate effect should be of short duration. Barlow, 
( 86) in experimental work on re rs has found that pre-
medication with 22.5% of the lethal dose of nembutal 
intensified the anesthetic prope "ties of nitrous 
oxide. He, ( 86) concludes, "correlation of the p:remed-
ication values of avertin and the nine barbituric acid 
deriv<ctives indicate th&t the order of efficiency from 
high to low is as follows: nembutal, avertin, dial, 
allonal, neonal, phanodorn, pernocton, luminal, amytal, 
and barbital." 
Dr. I.W. Magill, (66) admlnistered nembutal as a 
be-sal hypnotic to 262 surgical pa ti en ts, the intravenous 
route being used. When nembutal is administered intra-
venously the effect is rapid, says Volwiler; (59) 
responses to questions gradually become more indistinct 
end, without any period of excitement, the patient passes 
into a quiet sleep. None but a trivial fall in blood 
pressure was observed by Dr. Magill, (66) in any case 
in which nembutal wrs administered intravenously. By 
the intravenous method the amount of supplementary Fnesthetic 
required was less than with oral or rectal administration; 
also the postoperative sequelae were more marked following 
intravenous than following oral or rectal administration. 
Some degree of restlessness postoperatively was noted in 
only VS cases. Dr. Magill, (66) regarded nembut:al es the 
most outstanding anesthetic dru~ i'nd one sure to be of 
great value in med:i.cvl practice, i.e., in epilepsy, 
convulsions, eclampsia, delirium tremens, hysteria nnd nny 
nausea. 
In discussing Dr. Magill's paper, Sir FrEncis Shipway, 
(104) s~id that there seemed to be a ~reat future for 
nembutal; he we s using it constr"'1ntly and saw no di sad-
vantan:es from its use. Dr. Sttlnley Rowbotham, (105) 
unhesitatingly endorsed Dr. Magill's conclusions in regard 
to nembutal. He has administe~ed it in 108 cases and 
st&-t,-s that comp1c1 red with his experience with sodium amytal 
and pernocton there is no doubt th&t it is the best of 
the three drugs. In the majority of his cases there 'Vas 
a fall of 10.-15. rrnn. in the systolic blood pressure with 
nembutal whereas with amytal, the fall was usually double 
this amoi..mt, and postoperetive restlessness was decidedly 
more mE1rked. With pernocton, he reports that the results 
we~e even more unsatisfactory. Dr. Jas. Riddell, (106) 
states that as B. ureliminary sede.tive in nervous pRtients 
he found nembutal valuable and easier to employ than avertin 
per rectum. In his expe!'ience also it ls preferable, in 





John D. Graham, (107) states that the advantages 
possessed by nembutal are minimal dosa~e, more rapid 
elimination, greater freedom from after complications, and 
less tendency towards extreme restlessness or delirium. 
However, valuable as the drug is intravenously, in 
gynecological surgery, he states, it like other intra-
venous drugs has no nlace in obstetr:tcs, but is very 
effective and efficient in this field when given intra-
muscularly. 
John s. Lundy, (6) in his report on nembutal states 
that it is definitely sedative, antispasmodic and, of 
course, hypnotic. He reports a series of 2,300. cases 
in which nembutal was used intravenously to produce 
anesthesia. In this series 0.5 grams of nembutal was 
first dissolved in 7.5 c.c. of water so that the concen-
t~ation was one graln per c.c. For adults the solution 
WBS injected at the rate of 1. or 2. c.c. per minute. 
The effect of the fjrst gr&in was hardly anparent. After 
two grains were given the patient spoke of a definite 
effect; after three p;rains there was a general feeling of 
neFce and well-bejng; after four grajns, the patients 
usually fell Psleep but were not anesthetized; after five 
greins the petients were more deeply asleep but not anesth-
etized; after six grains the patients were in begtnning 
anesthesia; after seven grains anesthesia was usually 










few cPses in which anesthesia was not comolete. 
Geor;;i:e Carroll, (5) champions the use of nembutal as 
a sedHtive for prelimin~ry medication to local, general 
and spinal anesthesia. He states that in preparing the 
patients for operation, as in emergencies, accidental 
and traumatic injuries, the rapid effect, small dosaRe 
and short duration of effect is advantageous. Also, 
while nembutal is not -intended as &. lone anesthetic, 
properly graduated dosage will produce a degree of anesth-
esia under which much can be done without additional use 
of other agents. He, (5) states that in properly select-
ed cases under skillful manipulation, extensive surgery 
may be done with the employment of locEil infiltration or 
a very small amount of inhal1ction anesthesia. Its use 
in local and spinal ~nesthesia has been found to raise 
the toleN1nce to normal and reduce to a minimum the 
liability of disagreeable reactions and sequelae, and 
the recovery period is rapid, due to the small amount 
of &nesthetic required, and is usually unaccompanied by 
nausea or vomiting, with a period of sedation li:sting 
several hours. 
Where time is an element of consideration, this intra-
venous method is most satisfE;ctory. According to Carroll, 
(5) considerable lattitude in dosage was found necessary 
due to the j_ndividual reaction, where effectiveness WES 
observed to v~:ry with age, and general physical condition 
and the dose required to produce sleep was best determined 
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by the rate at which the subject became unconscious. As 
re~ards the nembutal solution itself, he points out that 
the solution should be freshly nrepared for eRch case as 
it hydrolyzes in aqueous solution, and only perfectly 
clear solutions should be used. In his cases, there has 
heen no nauseH or vomiting, the blood pressure frequent-
ly fell slightly at first, only to return to the previous 
level or above in a short time. The resnirations became 
lessened in amplitude, the rate slowed, but no cyanosis 
was ever observed. 
The contraindications are, as :tn P'eneral anesthesia, 
the a~ed, high or low blood pressure, arterioscle~osis 
and unstable cardio-vascular systems, pulmonary involve-
ment or edema about the neck or throat. Carroll, (5) 
states that the chief dangers are broncho-pneumonia, and 
postoperative pulmonary edema, but th::;t these are noted 
only after excessive doses, and that nembutvl should not 
be given 6fter large doses of morphine, nor should it be 




As the chemists of the firm Riedel did not succeed 
at the time, in spite of indefatigable efforts, in re-
movlng the exciting properties of the anesthetic per-
nocton injection, by modifying the nnture of the solvent, 
it was, as a result, taken for G'.rEmted that the excitat-
ion of reflexes was a property of all brrbituric acid 
derivatives, so that we had practically given up the 
hope of finding an injectable anesthetic suitable for 
practic::,l use. 
Nevertheless, Weese (44) succeeded recently in dis-
covering evipan-sodium, a derivB-tive of barbituric acid, 
which does not nossess the undesirable properties of all 
injectable anesthetics known up to now, particularly those 
of amytal and pernocton; on the contrary this new product 
shows a considerably s:;reuter solubility, as well as the 
property of a more complete splittin~ up and decomposition 
of its molecule within the organism. 
Evipan-sodium is the sodium salt of evioan, i.e., of 
N-methylcyclo-hexenyl-methyl-barbituric scid, which latter 
substance we_s produced by Kropp and Taub, and was introd-
uced at the time by Weese. Weese, (44) reports that in his 
exneriments with evipan, he was impressed by the most strik-
ing fact that in comp<~rison with other derivfatives of barb-
ituric acid, this particular one caused an extraordinary 
rapid and deep sleep withovt after-effects-and without 
causing any symptoms of excitement. Weese also noticed 
at the time, that the margin-between its minimum anesthetic 
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and toxic doses is very large and that only several 
Bnesthetic doses have a fatal effect. On the bH sis of 
these observations, efforts were mede to create an 
injectable anesthetic for the purpose of short anesthesia, 
which resulted in the nroduction of a sodium selt of 
evipan. 
Evipan-sodium, also called endorm, is a whitish sub-
stence readily soluble in water. Organic sol vents have 
also been found recently, in which evipan keeps permanent-
ly. (44) The manufacturers state for instance that the 
evipan concentrate represents a 33M6 solution of the sod-. , 
ium salt in methyl-diglycol. Consequently, there was at 
first, for practical purposes, two different kinds of 
ampoules, i.e., 1. Ampoules containing a definite weight 
of the sodium salt, for the preparation of a 10% aqueous 
solution. 2. Ampoules containing a 33t% solution of 
evipan-sodium dissolved in methyl-diglycol, which had also 
to be diluted before use with 10. c.c. of sterile water, 
so as to obtain a 10% solution. The latter form is now 
the usual form, and the one that is used commercially. 
Weese, (44) seems to h~ve searched from the very 
beginning for a product for producing a short general 
anesthesia by injection. In feet, he directed his 
attention mainly to the rate of decomnosition of the said 
substronce. As a matter of fact during the lH st few years, 
both phhrmacologists and clinicians have realized that 







careful consideration and represents a much more import-
Bnt factor when considering the apnlicability of a prep-
aration than the factor of the difficulty of absorption 
by the circulation. 
The curve of evipan-sodium anesthesia, is similar to 
that of all injection anesthetics, and as sh0wn recently 
_by Rehn and Killian, (45) for pernocton in their critical 
survey of our an sthesia processes, the rising is very 
steep and depends not only on the concentration and on 
the total dose of the product, but particularly on the 
rate of injection. If this is made with mode~ate speed, 
the anesthesia curve runs ~ n such e. manner that the action 
~ives the me?:csure both of the speed of the injection and 
of the dose injected. However, the culminating point of 
the depth of sleep and the anesthesia curve is always 
attained after the end of the injection, i.e., after 
from 5-10 minutes a point if reached which must be taken 
into consideration. On the other hand the downward curve 
of evipan-sodium anesthesia, when compared with that of 
other barbituric acid derivatives, is extraordinarily 
rapid, so that both experimentally and clinically, when 
using medium doses, one may reckon upon the awakening of 
the patient after 15-30 minutes. 
The liver must be considered &s the principal de-
toxicating organ, seeinp; that experiments have shown that 
hepetectomised animals, or animals which hPd been poison-
ed with phosnhorus and whose liver was consequently very 
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damaged, awoke much more slowly. According to Weese, (44) 
evipan-sodium is hardly destroyed in the blood, the kid-
neys also do not participate in the process of detoxicat-
ion of chem5.ca1 decomposition. He found traces of unchang-
ed evipan-sodium in t.he urine. Animals which had been 
submitted to repeated anesthesia over a period of several 
months exhibited no manifestations of tolerance, nor .could 
?ny injury of the organism be observed. 
The exceedingly good results obtained with animals, 
encoura~ed the experimentul application of evipan anesth-
esia to human beings. Evipan-sodium anesthesia has been 
used bv one author alone, H. Killian, (44) in over ten 
thousand cases without any certain case of death having 
become known. Generally speaking, everything th8t has 
been learned rep;arding evipan anesthesia when applied to 
animals, has been confirmed with human beings. 
The packa~es intended for use in clinics contain 
each, two ampoules, i.e., a small ampoule with a quan-
t:tty of dry evipan-sodium or with evipan-sodium diss-
olved in methyl-di_g:lycol which is just sufficient, when 
mixed with the 10. c.c. of sterile wat~r contained in 
the lFrger ampoule to make the solution ready for use. 
The _technique of the injection is extremely simple and 
requires no special preliminary knowledge. The only 
im:oort<·nt point is the difference P..S compared with 
injections of pernocton. Seeing that evipan-sodium 
is much mo ·e soluble and much more easily decomposed, 
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it is not necessary to rr~intain such a slow rate of inject-
ion t,s in the case with pernocton. On the contrary, ex-
perience has shown that, when inducing evipan-sodium 
anesthesia, it is pos~dble to influence the duration 
of anesthesia and the depth of sleep by an adequate 
rate of injection. The indications of thE: various authors 
show that they hav"' not B.11 carried out the injections in 
the same wny, but th&t there are slight differences. 11.t 
the start, the firm that manufactured this product, set 
down a fixed rule for dosc-.ge on the kilogram per body 
weipp_t scale. However, all those who have taken up the 
new method and ha v~; expressed an opinion, agree that it 
is neither desirable nor necessary to fix the dose in 
rel&tion to the bodyweight of the patients. 
H. Killian, (44) adopted the method of detern1·inlng 
the dose according to t.he anesthetic effect. He gives 
a maximum dose for a single injection. Thus Ernst 
never exceeds 9. c.c. of evipan, whereas Baetzner 
mentioned 10. c.c. as t1:1e highest permissible dose 
per injection. Only Holtermann, (44) who llkewise 
conside2:·s 10. c.c. as the normal maximum dose, has, 
at different times, injected, in indi1ridlH.l cases, 
15. c.c. of tb.e 10% solution without ever having ob-
served any visible damage. Other workers are said to 
have injected even from 30.-60. c.c. without any harm. 
l''or an f,.verage evipan anesthesia, in 'Nhich sleep 
nmst last from twenty to thirty minutes, in order to 
------------------
8dapt the rate of injection to the purpose, about 3.-4. 
c.c. are in,iecte'i in the first mtnute dur~ng which the 
p~tient quickly falls asleep, and an additional 3.-4. 
c.c. A.re injected fractionally, in such a V'1ay that the 
respirs.tion and color of tr1e sidn are not ma.terially 
modified during the injection. The total dose required 
for every individual d§se is adjusted during the injection 
in accorde.nce with the depth of sleep, i.e., the inject-
ion is simply stopped when the operator has the impress-
ion that the pr:...tient•s sleep is deep enourrlJ.. Naturally, 
the dose is regulated in E-ccordance with the physical 
condition and the age of the patient. 
Injections have been made in patients sufferin~ from 
diabetes, from dise&ses of the heBrt, lungs, liver and 
kidneys without any undesirable effects so that one can 
conclude that evinan constitutes a preparation which is 
p~ rticult'.rly suitable for patients who are seriously ill. 
(44) In these cases, evipan anesthesia replaces especially 
the strong inhalution anesthetics, avertin, regionr.l and 
spinal anesthesia; it also r'=·places gas anesthesia with 
ethylene or narcylene when dea.lj_ng with arteri.o-sclerotic 
natients or typnotic subjects. 
If it is desired to use evipan only with a view to 
initiate a.nesthesia with other anesthetics, such i:;s gas, 
ether, chloroform, remarkably small doses will render the 
patient unconscious. Three to four c.c. o.f the original 
solution are often sufficient even with patients of a 
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strong conRtitution. Furthermore if j_t is simpl:r desired 
to perform to a short operation, such as can be carried 
out under ethyl chloride anesthesia, it is recommended 
to inject a small dose of evipan comparatively quickl;r 
i.e., 3.-5. c.c. within one n:inute, observing closely 
the patient's respiration. The above dose passing quick-
ly into the blood stream, produces within a surprisingly 
short time a depth of sleep correspondin~ at least to 
the first section of the tolerance stage. (44) 
The distribution of this comp&ratively small dose of 
evipan in the tissues and its decomposition take place 
so rapidly that after five minutes, alrei:1dy the quantity 
present in the blood is no longer sufficient for anesthesia. 
Consequently this mode of application of evipan makes it 
possible to obtain a light anesthesia of three to five 
minutes duration, which, in contradistinction with anesth-
esias of the same degree obtained with gas or ethyl chloride, 
causes no unpleasant subj ecti '-Ie react ion vrhatever for the 
prtient, with exceution of the injection itself, and 
contrary to what happens with gas nercotics, the patient 
remains in a slightly drowsy condition for about an hour. 
The cases of cessation of respiration observed 
occasionall;r with evipan anesthesia nrust probably be 
attributed to the preliminary administration of lnrge doses 
of mornhine or similar active products, a fact which has 
escaped the attention of some observe~s. (43) As evinan 
anesth2sia is not only complete, but sets in within a 
85. 
very short time without discomfort for the patient, 
there is not the slightest reason for influencing pure 
evipan anesthesia by the use of alkaloids. The admin-
:i st ration of a preanesthetic agent h• s also been abandon-
ed by most clinicians 
Holtermann, (44) gives the most exact description of 
the symptoms of evipan aneEthesia. After evipan inject-
ions the respiration as a rule does not remain at. 1-he 
normal level, but as the depth of sleep progresses, the 
breathing becomes simultaneously slower and somewhat 
deeper. According to the clinical measurements, during 
the period of increasing anesthesia a transitorv depress-
ion of the respiratory activity takes place, which in-
creo.ses with the speed and volume of the injection. As 
with all preparations of tht:.t nature, it fi-~st manifests 
itself by a diminution of frequency which is compensated 
by a deepening of the successive respiration with a 
comparativel;r swift fall of the functional activity 
which in many cases caused slight cyanosis or even a 
temporary failure of the respir1°tion of a non-danrzerous 
character, The modifications of the respiration are there-
fore the best guide for correcting the sneed of injection. 
After the respirfJtory depression which takes nlace during 
the first few minutes, that function is usually soon re-
store& and a moderHte hyperventilation may take nlace 




The blood pressure falls during the injection and 
generally returns to a level which is 5.-15. mm. of 
mercury below the original figure, thus practically never 
causing any great anxiety. The falling blood nressure 
deuends entirely on the ra~e of injection. The quicker 
and more carelessly the inject ions are mrtde, the deeper 
is the initircl fall. As in the case with all such anesth-
esias, the pulse rate increases somewhat, simultaneously 
w1 th the modifications in the blood pressure; the average 
ircrease as given by Holtermann, (44) is from 10-30 beats 
per minute, but according to Killian, (43) the pulse rate 
generally fHlls e_gain somewhat when the tole •·ance S 4 age 
is re11ched and goes back to approximately the normal rate 
according to the nature of the intervention. 
Generally speaking, only very seldom have complications 
been observed in the use of avipan. Only on a few occasions 
have disturbances of the respirations been observed at the 
end of the injection, these being probably due to a too 
ranid injection into oversensitive subjects. Baetzner, (44) 
reports that in isolat0d cases, after completion of the 
injection, the face of the patient became bluish and the 
respiration shallow, a condition however which quickly 
passed off. 
Up to the present time, evipan anesthesia has tw.inly 
been used for light an<?sthesia or short anesthesia; snd 
only to smaller extent for full anesthesia in cases of 
sur~ical interventions of average severity. In complete 
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agreement with the views of most clinicians, Ernst, (44) 
emphasized th&t its slight influence on the circulation 
and respiration, as well as its comparative harmlessness 
as regards liver and kidneys, permit of its use to the 
widest extent; that generalanesthesia with evipan is now 
possible with old patients with damaged he~rt, in whose 
case surgeons hesitated up to now to use other- methods 
of anesthesia. Disease of the excretory organs ~nd of the 
liver hav·~ not disturbed up to now the favorable course 
of anesthesia., nor hns the nnesthes:i.a h2d any prejudic-
ial influence on the course of the disease, even when 
the same patients have been subj ecter.'l repeatedly to 
evipan anesthesia at short intervals. 
As no symptoms of habituation appeared, evipan 
anesthesia according to the experience of all authors, 
f can be resorted too as often as desired and can con-
-~ 
sequently be repeated without danger on the same patient. 
Evipan anesthesia is used mainly for short anesthesi_a 
or fo.r the inducement of full anesthesia with gas or a 
mixture of pas and ether. An exact specification of 
indications has not been possible up to now, seeing that 
ion will be necessary with oatients wlth diminished 
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respiratory surface or otherwise impaired ventilation; 
Also, in the case of sub-uremic patients or subjects 
suffering from severe liver affections. The only in-
fluence on the field of indications ls in regard to the 
duration of sleep, j_f, for the above mentioned reason, it 
is not desirable to make use of additional doses. It 
cBn a.t any rate be stated that, p.;enerully speaking, evipan 
anesthesia replaces light and protracted ethvl chloride 
anesthesia, also solesthin anesthesia, light ether anesth-
esia, short ether anesthesia, and to a certain degree also 
gas anesthesia. 
If we now summarize all the data relatinP: t.o the new 
preparation, we can asFert that evinan takes a pre-
eminent place in comparison with all the injection prepar-
ations of the barbituric acid class useci un to now, on 
account of its being easily soluble and of its repid de-
composition, and that it will gain a predominFnt influence 
in the field of anestheBia. Whether it will supplant 
entirely pernocton which produces a considerably longer 
sleep of lesser denth, remains an open question for the 
time being. 
The statistics which have been compiled up to now 
include over 15,000. cases in which evipan has been used 
mainly as a light or short anesthetic with only one certain 
case of death. These statistics are so extremely favorable 
that one cannot only recommend the method with conviction, 





in wl--dch short, or light types of anesthesia are desired. 
In conclusion it may be said that e'rinan affords an 
excellent, quick a.cting anesthesia for short operations. 
Likewise, it is a reliable induction anesthesia for major 
operations. The smaller amounts of the added anesthetic 
then used to deepen the narcosis is an advantage. Evipan 
can be successfully combined vdth ether, nitrous oxide, 
local or lumbar anesthesia. The evipan affords a com-
ulete sta~e of tolerance, its action is short and certain,. 
the nost-anesthetic sleep is short, bad after effects are 
rare, its action is safe if the contraindications are 
observed, and the technique is simple. If evipan is 
properly used and with the caution advised by those 
clinicians acquainted most closely with it, one will 
only be able to reccommend it. (44) M. Babcock, (81) 
does not se 0 m to be of auite the snme opinion as to 
the contraindications, and states that the contra-
indications for its use are so definite that he believes 
it will find but a limited field of usefulness. Hypo-
tension, severe pulmonary infection, heart lesions, and 
pEit:leni· 1 s suffering from wasting diseases, he thinks 
should not be given evipan. Che.s. F. Hadfield, (80) 
states that he hhs tested out evipan, and found it 
quite favorable and issued such a report. He also states 
th~·t evipan hns been well received after much thorough 
discussion by The Joint Anesthetics Committee of the 
Royal Society of Medicine. L:i eber, ( 23) states that 
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the drug evipal, is new only in the sense that it hns only 
recently become availahle in this country. He says that 
it has, however, been extensively used abroad, and in two 
years from the time of its isolation by Kraft and Taub, 
it hEd been administered well over 60,000 times. All 
of this work, seemed to him to show that this drug was 





Increase in the nse of Intravenous anesthesia has 
been delayed because of lack of a suitable agent, but at 
times when a general anesthetic is needed the intravenous 
method is the best; (20) for example, if the cautery or. 
diathe1•my is to be used, and thus an inflammable a.o:ent 
would be dangerous, or if portability is of importance. 
For intravenous anesthesia the barbiturates, particular-
ly, h&ve been employed. (8?) 
It was stressed by Lundy, (AS) and others, that 
nembutal was different from the other barbiturates in 
common use, ln th&t it w&s a relatively shorter acting 
drug. Then, still shorter acting barbiturates were 
sought, and most of what follows will deal with two 
of the newest barbiturates introduced quite recently 
by John s. Lundy and his co-workers. 
In 1934, Lundy (20) began to use a still newer 
type of barbiturate, sodium ethyl 1-methyl butyl 
thiobarbituric acid, employment of which was attended 
by .fair relaxi:.tion, short anesthesia, quick recovery, 
and absence of restlessness in almost all cases. (20) 
With the exception that oxygen is replaced by sulphur, 
this agent is ·the same as nembutal. This druo.: is 
apnroximately 33-50% stronger than evipan. It comes 
in an ampoule, together with a companion ampoule of 
sterile water. The solution used is 10%, and must be 
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clear. 
Another barbiturate, sodium allyl secondary butyl 
thiobG.rbituric acid, referred to elsewhere as "barbiturate 
B", has been used in a few cases with results similar to 
those obtained with sodium ethyl 1-methyl butyl thiobarb-
i turic acid. To avoid the long chemical names, I shall 
revert to terms used •lsewhere and already mentioned in 
this paper; thus, sodium ethyl 1-met.hyl butyl thiobarb-
ituric E.cid will be called barbiturate B. Although 
barbiturate B is less potent than barbiturate A, it is 
about as potent as evipan. Lundy, (20) prefers barb-
iturate A to barbiturate B in surgical cases for the 
same reason that he prefers nembutal to sodium amytal 
for surgical cases; because he wishes to use a minimal 
amount of drug to produce a given effect, anticipating 
that, .at. leastin the average patient, the effect will 
be characteristic and that in the unusual case, fewer 
varhitions will be noted ths.n if a larfter quantity of 
another drug h~,d been given. 
The method of giving barbiturate A and barbiturate B, 
resembles that used in giving evipan. An empty stomach 
is desirable, if not essential, and if the nE:ttient has 
nY·terial in the stoffiach, it should be emptied. To ad-
minister barbiturate A safely, the dose is two-thirds 
to a half as much &s the dose of evipan. In adrninis-
tra tion, the airway must be kept patent. Respiration 
may be depressed, and it is not sufficlent to see the 
resniratory movements; there must be evidence of respiratory 
exchange. Lundy, (20) puts a wisp of cotton over the nose 
and mouth and observes its motion. 
The advanta,~e of these short-acting barbiturates 
over other general anesthetics, and over certain local 
anesthetics, is in proportion to the brevity of the 
operation. Operations or painful procedures, especially 
minor ones, lasting up to ten or fifteen minutes, are 
satisfactory fields for these drugs. (20) F'or ambul-
atory pstients undergoing distinctly minor operations, 
local anesthesia may be preferred. If the operation is 
of longer duration or is a major one, it is only in spec-
ial capes thl:' t these short-acting a'J'.ents E~ re pc.rticularly 
useful. For example, barbiturate A has heen used quite 
satisfactorily to produce anesthesia for three and a half 
hours, in a case of brain tumor complicated by pulmonary 
tuberculosis. Although, according to Lundy, (20) thirty 
four and one half grains were given, there were no ill 
effects. A Magill intratracheal tube provided an air-
way; it also furnished a means of artificial ventilation, 
and of administering an anesthetic by inhalation, if these 
had become necesFary. 
Barbiturate A is useful in small doses, to produce 
unconsciousness for induction of anesthesia by inhalation, 
particulf' rly if patients h8-ve facial dEo'fects. Short <"'.Ct-
ing barbiturates are indicated for intravenous ad.minis-




~ Lundy, ( 20) se<:>ms to differ from a great many other 
workers, in his opinion of the value of pre-mediccition. 
He states that he has found it advantageous to give 
mornhine hypodermically, and nembutal by mouth, in small 
doses, to adults, preliminary to administration of the 
newer barbiturates, especially in the use of barbiturate B. 
With barbiturate A it is less important to give preliminary 
medication, because of the increased potency of the drug. 
He states, however, that less of either drug will be need-
ed if prelimini:'ry medication hi: s been given than if it 
has not been ~iven. He cites rhe example of patients, 
who have had morphine, nembutal and atropine a~ medication 
before administration of barbiturate A, a'Nakening in the 
course of the operation, giving no evidence of pain at 
the time, and answering questions readily, and then hav-
ing no memory of either pain or the questions afterward. 
This maintenance of analgesia in the nresence of return 
of consciousness was not noted in all cases in which pre-
liminary medication had been given, but was never noted 
unless preliminary medication had been given. (20) 
The patient does not perspire when these new agents 
are used and, in some cases, the:ne has been noticeable 
absence of postoperative shock. The blood pressure falls 
when a ler.o.:e dose is administered. The patient, accord-
ing to Tovell, (11) usually awakens quietly and there is 
seldom any nausea or vomiting. Also, he states that as 

















administration of each successive dose is increased. Un-
consciousness produced by a large dose is of long duration. 
These newer barbiturates, are of such compFratively 
recent origin, that extensive literature concerning its 
use, and efficiency are not obtaina9le. Not enough work 
has been done on them, at present, to warrant a logical 
decision as to their applicability to clinical medicine. 
For this reason, I am presenting them only as an example 
of some of the results obtained by those who are in a 
constant search for a new ideal drug, which when given 
by the intravenous route, will produce an anesthesia of 
the most desirable quality. The ideal agent for routine 
intravenous anesthesia has not been found, ['S yet, but 
the available agents have been found by most, to be 









Among clinicians, there is a CTreat deal of interest 
in this question of intravenous anesthesia. Inhalation 
anesthesia has been brought to a high state of usefulness; 
locfi 1 and regional anesthesia too, hr~ve been so perfected 
that they are useful and safe, and rectal anesthesia by 
the use of avertin, has advanced also. Intravenous 
anesthesia, using ether in saline solution, has remained 
undeveloped. The long-actin~ barbiturates were not safe 
because they produced restlessness that sometimes was 
difficult to control and tended to produce pulmonary edema 
end bronchopneumonia. Now, we hhve drugs that nermit 
quick induction of anesthesia by the intravenous method 
which, in some cases, also produce analgesia. 
Despite all of the improvements &nd progress that has 
been made in the last twenty years in the field of anesth-
esia, surgeons, chemists and pharmacologists are still 
seeking the ideal anesthetic. None of the previously 
discussed dru~s quite fit the picture or measure up 
completely to the stFndards of this acme of anesthesia. 
No single standard csn be held up as the requirements of 
the ideal drug, but after a perusE~l of various discuss-
ions of this subject, I have attempted to c omnile an 
r-'rbi trary set of stf1ndards. In relieving the patient 
of pain and mental anguish during the ope,,..ation, the 
ideal anest !etic will not bring added terrors of its own. 
9'7. 
The patient will not remember the anesthetizing process 
as a hideous nir:htmare, and the worst part of his operat-
ive experience. The postoperative nausea of ether still 
remains one of the most revolting memories that the patient 
retains. 
Secondly, the ideal anesthetic will induce anesthesia 
as gently, as quietly and as naturally i;s sleep itself. 
No longer will the patient be plunged into a seemingly 
endless eternity after a short period of consciousness, 
and therefore terrifying, struggle against suffocation. 
Thirdly, it will be an anesthetic without irritat-
ion to organs of the body in its adm:tnistration and 
elimination. It will not add to the hazards of the 
operation by inimical effects of its own such as ether 
Droduces in the air passages, chloroform upon the liver, 
~nd cocaine upon the nervous system. 
After a thorough inve stlgh t ~.on of +:hL-' p:. .. obla:_ of' 
r ~'."'-e:r.J. ti:·.c anesthesla thro•ish thi;.J enployment of the 
intravenous route, and after reading articles, pro and 
con, sponsored by enthusiasts of ehch side of the question, 
I have, myself, rather reached an non the fencen attitude, 
and although I definitely am of the belief thc:+~ anesthesia 
solely b;T this route, is not at present a plausible idea, 
I do think that there are certain indications, previously 
discussed, which definitely offer a field for intravenous 
anesthesia. The old theories and practices of employ:ing 
ether, hedon.sl,somnifaine, paraldehyde and isopral, are 
'11 llflM•iiif 
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definitely outmoded, and although they once were used 
fairly extensively with success, l believe that we can 
dismiss them from the final analysis, as merely being of 
historical value, and useless j_n the light of practical 
present-day modes of producing anesthesia. 
The next group of drugs of importance- can be 
sunurn rize 1 under one heading; the use of barbiturates 
intravenously. My present belief is that the use of the 
barbituric acid derivatives administered intravenously 
promise to offer a worth-while adrii ti on to the armament-
arium of +-he physician. I doubt the adv1:1ntar-;e to the 
surgeon of the use of thrise derivatives which result 
in many hours or days of depression. I believe that the 
use of the quickly detoxified barbiturates do slip-,htly 
constitute, a very valuable background upon which to 
superimpose general anesthesia. None of the barbituric 
acid derivatives, at present available, appears to be 
a true anesthetic substance, and hence should not be 
considered for the replacement of the well established 
volatile and controllable anesthetic. 
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